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ABSTRACT OF DISSERTATION 
by Neal Dwain Byington 
FLOW INJECTION ATOMIC ABSORPTION ASSAY OF COPPER AND ZINC IN THE 
PLASMA OF AGE DEPENDENT AUDIOGENIC SEIZURE SUSCEPTIBLE MICE 
Flow injection atomic absorption procedures with less than 
10%RSD at 1.0 ppm were developed for the assay of copper and zinc 
in 10 11L samples of mouse plasma. The flow injection apparatus 
was designed with a pulseless liquid flow control system, regulated 
by inert gas pressure. The aspiration liquid is 6% t-butanol in 
water. After exhaustive parameter optimizations, copper assays 
were conducted with the conventional air-acetylene flame at 
324.754 nm and zinc assays were conducted with the unconventional 
argon-hydrogen air diffusion flame at 213.856 nm. The argon-
hydrogen flame system was chosen because it abs.orbs very little 
ultraviolet light. 
The developed methods were used to determine the concentration 
of copper and zinc in plasma samples from six strains ( C57BL/6J, 
LG/J, DBA/2J, SJL/J, BALB/cJ, LP/J ) of male and female audiogenic 
seizure susceptible mice, aged 18 to 65 days. The results are 
presented in 24 sets of data and graphs of metal concentrations 
versus mouse age. 
The copper concentration, within the preclSlon of the data, 
is 1.2 ppm i 0.2 SD for all sexes, strains, and ages. The zinc 
concentrationj within the precision of the data, increases from 
1.2 ppm+ 0.2 SD at twenty days of age to 1.8 ppm i 0.2 SD at 
sixty days of age for all sexes and strains. 
There is no correlation between ·the age dependence of the 
seizure susceptibility of any sex or strain of mice and the plasma 
concentrations or concentration ratios for either copper or zinc. 
At any age there is no correlation between the relative seizure 
susceptibility among the strains of mice and their concentrations 
or concentration ratios for either copper or zinc. 
The results cast doubt on the significance of copper and zinc 
concentrations for the epilepsy of humans receiving anticonvulsant 
medication and on the validity of the use of audiogenic seizure 
susceptible mice as a model for epilepsy. Additional experiments 
are suggested. 
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ABSTRACT OF DISSERTATION 
FLOW INJECTION ATOMIC ABSORPTION ASSAY OF COPPER 
AND ZINC IN THE PLASMA OF AGE DEPENDENT AUDIOGENIC 
SEIZURE SUSCEPTIBLE MICE 
less than 10 %RSD at 1.0 ppm were developed for the 
assay of copper and zinc. in 10 wL samples of mouse 
plasma. The flow injection apparatu.s was designed with 
a pulseless liquid flow control.system, regulated by inert 
gas pr·essure. The aspiration. liquid is 6% t-butanol in 
water •- After exhaustive parameter optimizations, copper 
assays were conducted with the conventional air-acetylene 
flame at 324.754 nm and zinc assays were conducted -vli th the 
unconventional argon-hydrogen air diffusion flame at 
213.856 nm. The argon-hydrogen flame system was chosen 
because it absorbs very little ultraviolet light. 
The developed methods were used to determine the 
concentration of copper and zinc. in plasma samples from 
six strains( C57BL/6J, LG/J, DBA/2J, SJL/J, BALB/cJ, LP/J) 
of male and female audiogenic seizure ~usceptible mice, 
aged 18 to 65 days. 
XV 
I 
I 
The results are presented_in .. 24 aets .. of.data and graphs 
of metal concentDations .. versus mouse age. 
The copper concentration, w.ithin .the precision of the 
data, is 1.2 pp~ .. + 0.2.SD for all sexes~ strains, and ages. 
The zinc· concentrat~on, within.the .precision of the data, 
increa.ses. f·rom. l .• ~ ppm ±· 0 ... 2 SD at. twent.y ·days of age to 
strains. 
There is no correlation between the.age dependence of 
the seizure su·seeptibilit.y of an.y; sex or s,train of mice and 
the plasma- concentrations or .concentration ratios for 
either copper.· or· .zinc. At any. age there is. no correlation 
bet~een the·relative seizure ·susceptibility among the 
strains of. m.ice and .their c0ncentra.tions or. concentration 
ratios for either cop.per or zinc. 
The resul.t.s. cast doubt on the. significance of copper 
and zinc concentrations for thB ep~lepsy of humans 
receiving- anticon.vulsant .. medication and on .the validity 
of the use of audiogenic seizure susceptible mice as a 
model· for epilepsy. Additional experiments. are suggested. 
xvi 
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CHAPTER ONE c 
1 • Atomic Absorption Flow. Injection Analysis 
Any chromatographi.c s.ystem includes the injection 
of a sample· into. a. co.ntinuo.usly. flo.wing stream of gas 
-----,o~r-J:-iqu-:td, separation of:--Glie. samp.Ie.·i.nto components as 
it is transported. through the ~eparation. column by the 
flowing· stream,. and. the t.rans.portat.ion of. the sample 
by the stream from the.separa.tion column· to and through 
the detector.. . The cont.inuous.ly operating d.etector 
produces som·e .. '.for.m of· output s·ignal. as a function of 
time as the·~ample.·passes thraugh,the detector. 
There· are, however,. man.y analytical procedures that 
do not requilfe:sep.ara.tion of the sample into individual 
components •. They only require de.tection of the injected 
sample by an .analysis specific detec·tor or the reaction 
of the injected. sample· ivi.th a reagent followed by detection 
with an analysis specific detector. This. type of 
continuous flow.analysis, with its origins in gas and 
liquid chromatography, was developed,.by Skeggs (1), and 
required·the injectiqn of sufficient sample to obtain 
a steady state·~signal and air segmentation between the 
injected samples •.. Most automated. clinical analyzers 
operate on this basis. 
1 
I 
I 
Nagy~ Feher, and Pungor later simplified this 
concept· by ~liminating the requirement for the injection 
of sufficient sample to obtain a steady state signal and 
the requirement for air segmentation between the injected 
samples(2)~ Their system injected the sample into a 
flowing strea~ o~ electrolyte, mixed the sample and 
an electrochemical .. detector. They obtained sharp 11 gas 
chromatograph-type" peaks. 
This process was refined, patented, and popularized 
by Ruzicka and. Hans.en.( 3, 4., 5) and. later by Stewart and 
Hare(6) who restricted the sample and solvent strea~ 
mixing to diffusion. by. the use of narrow bore tubing. 
These groups called the.process "Flow Injection Analysis 11 • 
In its most general form it includes the injection of a 
sample into a continuous. stream of liquid or gas and 
the subsequent detection of that. sample by a detector. 
The analysis design may also provide for the mixing of 
the sample or the reaction of the sample by any process 
between the points of injection and detection. The 
2 
development of flow injection analysis, applicable diffusion 
mixing theory, applications, and instrumentation have been 
discussed b~ Betteridge(7) and Ranger(B). 
1.1 Atomic Absorption Flow Injection Analysis 
Wolf and Stewart extended the applications of flow 
injection analysis to atomic absorption spectroscopy(9). 
Their system. included a depulsed positive displacement 
pump, an automatic four or six port rotary loop injection 
3 
an automatic integrator or analog recorder. They automatical-
ly injected 25 to 300 ~1 of sample into the nebulizer of 
an atomic absorption spectrometer. 
Fukamachi and Ishibashi enhanced the sensitivity of 
atomic absorption flow injection analysis(10). They 
compared the sensitivities re~ulting from organic solvent 
streams with those from aqueous solvent streams. For 14 
metals, sensitivity enhancements were reported for methanol, 
n-butyl acetate, and methyl iso-butyl ketone streams. The 
largest sensitivity enhancement was caused by n-butyl acetate. 
This dissertation extends the sensitivity and 
application of atomic absorption flow injection analysis 
to small volumes of complex fluids such as plasma and serum. 
The sensitivity is enhanced by the use of mixed aqueous-
organic solvent systems, systematic procedures for the 
selection of optimal instrument parameters, and air-
acetylene and argon-hydrogen air diffusion flame systems. 
I 
i 
The use of the mixed aqueous-organic solvent system, 
6%(v/v) t-butanol in water, provides for enhanced 
4 
sensitivity and does not cause precipitation of solutes from 
complex fluids such as serum and plasma. This work is 
applicable to the. analysis of samples which are viscous, 
aqueous and/or organic, salty, and chemi~ally complex. 
The instrumental design is described in section 1.2. 
The experimental peak shapes are presented in Figure 1.1.1. 
The instrumental operating parameters and the experiments 
which led to their selection are discussed in section 1.3. 
In Table 1.1.1, minimal amounts of model compounds 
detectable by a very sensitive gas chromatographic method 
are shown for comparison of the sensitivity of this method 
to another very sensitive method(11). A. referenced 
comparison of metal analysis parameters by various 
techniques is presented in Table 1.,1.2. 
The instrumental parameters for this version of 
atomic absorption flow injection analysis were developed 
to provide a means of analyzing very small volumes of 
mouse plasma for copper and zinc at the 1 ppm concentration 
level with a percent relative standard deviation(%RSD) of 
10 percent or less. This was achieved. Minimal levels of 
3 ng for zinc and 4 ng for copper at a signal to noise 
ratio of 2:1 are detectable. The major advantages of this 
system are the sensitivity, lack of matrix interferences, 
precision, and speed of analysis. 
I 
I 
I 
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TABLE 1.1.1 
THE MINIMAL AMOUNT OF MODEL COMPOUNDS DETECTABLE BY USE OF A 
SILICON DOPED HYDROGEN ATMOSPHERE FLAME IONIZATION DETECTOR 
Model Compound Minimal Detectable Amount, g 
---------------------'( S i_gnal to noise ra ti_Q_,.,~2,._,:u1_J.) ____ ---c: 
Aluminum hexafluoroacetylacetonate 
Ferrocene 
Chromium haxacarbonyl 
Tungsten hexacarbonyl 
Molybdenum hexacarbonyl 
Iron(III) trifluoroacetylacetonate 
Di-n-butyl sulfide 
Nitrobenzene 
Tetradecane 
2 X 10-12 
2 X 10-11 
5 X 10-10 
4 X 10-9 
4 X 10-9 
2 X 10-S 
2 X 10-7 
4 X 10-7 
Atomic Absorption Flow Injection Analysis Techniques 
This \vork 
Copper 
Zinc 
-
IE 
i 
~ 
!!' 
I 
I 
6 
TABLE 1.1.2 
COMPARISON OF METAL ANALYSIS PARAMETERS BY VARIOUS TECHNIQUES 
TECHNIQUE DETECTION LIMITS %RSD 
Cu Zn 
AA 0 .. 15 ppm 0.025 ppm 1-2 
AA-GF 0.6 pg 0.3 pg 5-200 
ICP 0.005 ppm 0.004 ppm 1-2 
DCP 0.002 ppm 0.003 ppm 8-10 
FIA-ICP Mn ( 10 ng ) 2 
FIA-AA 4 ng 3 ng 2 
FIA-AA 5 ng 5 
FIA-AA 4 ng 3 ng 2-10 
SAMPLE SIZE 
MINIMUM~ 111 
1000 
1-300 
1000 
1000 
25 
25-300 
50 
1-1 0 
-------------------------------------------------------------
IE 
~ 
il 
~ 
~ 
li 
e 
~ 
7 
TABLE 1.1.-2 (CONTINUED) 
COMPARISON OF METAL ANALYSIS PARAMETERS BY VARIOUS TECHNIQUES 
TECHNIQUE SOLVENT SAMPLE INTRODUCTION REFERENCE 
AA Aqueous/Organic Aspiration 12 
AA-GF Aqueous/Organic Syringe 13 
ICP Aqueous/Organic Aspiration 14 
DCP Aqueous/Organic Aspiration 15 
FIA-ICP Aqueous Loop Injector 16 
FIA-AA Aqueous Loop Injector 9 
FIA-AA n-butyl acetate Syringe 10 
-------------------------------------------------------------
FIA-AA 6%(v/v) t-butanol 
in water 
Syringe This Work 
-------------------------------------------------------------
-
!! 
~ 
I 
~ 
!! ; 
I 
~ 
-
E 
8 
TABLE 1.1.2 (CONTINUED) 
COMPARISON OF METAL ANALYSIS PARAMETERS BY VARIOUS TECHNIQUES 
AA Atomic Absorption Spectroscopy 
FIA Flow Injection Analysis 
DCP Direct Current.Plasma.Emission Spectroscopy 
GF Graphite Furnace 
ppm Part Per Million 
pg Picogram 
ng· Nanogram 
111 Microliter I 
I 
~ 
9 
FIGURE 1.1.1 
Experimental Peak Shapes 
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FIGURE 1 .2.1 
Flow Injection Apparatus 
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1.2 Instrument Design for Flow Injection Analysis 
A block diagram of the apparatus is given in 
Figure 1.2.1. The flow injection apparatus consists of a 
helium cylinder and regulatDr(I) which is connected to 
a 5 liter Millipore pressurized vessel(II) which is 
13 
connected to a 1/16" ·swagelok stainless steel tee injection 
port(IV) which is connected to the nebulizer on the Perkin-
Elmer Model 303 atomic absorption spectrometer(V). The 
atomic absorption signal from the spectrometer is sent 
to the recorder readout accessory(VI) and then to a Linear 
analog stripc~art· recorder(VII). 
The 5 liter Millipore pressure vessel(II) functions as 
a pulseless solvent pump. It is pressurized by helium from 
a conventional tank and regulator(!). The vessel is equipped 
with a pressure gauge and a valve at the solvent outlet. 
The flow restriction column(III) is a length of 
6 mm 0. D. x 16.7 em soft glass tube filled with Corning 
Controlled Pore Glass, CPG-10-500, with 120/200 mesh. The 
ends are 1/4" to 1/16" end drilled stainless steel Swagelok 
reducing unions with 2.0 micron pressed stainless steel 
filters. The ferrule is an Alltech 6 mm to 1/4" teflon 
reducing ferrule. 
i 
I 
The injection port(IV) is a 1/16" stainless steel 
Swagelok tee w·i th a septum at one end of the tee. The 
septum is cut from a regular blue Alltech septum with a 
#OO stopcock borer and trimmed to a cone shape with a 
single edged razor blade. Samples are injected with a 
14 
10 uL HamilJLQn~#-~Oj __ s~~ng~~------------------------------------------~ 
The tubing which connects the pressure vessel to the 
flow restriction column, the flow restriction column to 
the injection port, and the injection port to the nebulizer 
is 1/16" 0. D. x 0.023" I. D •. teflon tubing from Laboratory 
Data Control. All connections are done with 1/16" stainless 
steel Swagelok fittings. 
' 
I 
I 
------· ---·--------~-------
15 
1.3 Optimal Parameter Development.for the Instrument 
1 • 3.1 Analytical Wavelengths 
The choice of the analytical wavelengths of 324.754 nm 
for copper and 213.856 nm for zinc was made by an analysis 
energy levels, statistical waights of the upper levels(g), 
Einstein transition probabilities(A), Ladenburg oscillator 
strengths(f), and possibly interfering lines from other 
elements(1·7). The intent was to maximize the signal strength 
by the choice of ground state lines with large gA and gf 
values and to have all ROSsible interfering lines in the 
vicinity of the chosen lines be either from elements of 
very low concentration in the sample such as the rare 
earth elements or be non-ground state lines with low 
gA and gf values. These goals were ac.complished by a 
search of published experimental transition probabilities. 
Table 1~3.1.1 is a listing of the energy levels for 
possibly interfering lines which.lie within 0.65 nm of the 
copper line at 324.754 nm. Table 1.3.1.2 is a listing of 
the energy levels for possibly interfering lines which 
lie within 1.95 nm of the zinc line at 213.856 nm. 
The optical slit ~irlth of the spectrometer is 0.65 nm 
for assays· of copper at 324.754 nm and 1.95 nm for assays 
of zinc at 213.856 nm(12). Table 1.3.1.3 is a listing of 
16 
possible other element spectral overlap lines which lie in 
close proxim·i ty to the copper line at 324.754 nm and the 
zinc line at 213.856 nm. Lines which cause spectral overlap 
generai:i:y Tie wr-cni~O--;-i nm of~he analytical line. 
A series of absorbance.tests for metal interference was 
conducted to determine if other metal solutions would 
absorb at the copper or zinc wavelengths. The test solutions 
were 1000 ppm atomic absorption standards •. Table 1.3.1.4 
lists the metals tested and their absorbance at the 
analytical wavelengths for copper and zinc of 324.754 nm 
and 213.856 nm respectively. 
A small negative absorbance from chromium and a small 
positive absorbance of similar magnitude from nickel were 
observed at the copper ~v-avelength. The magnitude of the 
absorbance is equivalent to a copper concentration of 
approximately 0.25 ppm. This is ~onsidered insignificant 
when compared to the 1000 ppm standard.These small 
absorbancies are-of unknown origin but may be due to 
impurities in the standard solutions. None of the other 
1000 ppm metal solutions tested produced any detectable 
absorbance at·either the copper or zinc wavelengths 
i 
I 
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TABLE 1.3.1.1 
Ground State Lines Near the Copper Line at 324.754 nm 
for Various Metals 
324.104- 324.754- 325.404 
~Iavelength He tal Energy Level gA gf log gf 
nm °K 108/sec 
324 .. 754 Cu I 0 
-
30784 4.1 0.64 -0.19 
324.140 Eu I 0 30842 0.082 0.13 -0.89 --~ 
324.603 Eu I 0 30798 0.40 0.06 -1 .1 9 E ~ 
~ 
324.755 Eu I 0 
-
30784 0.89 0 .. 14 -0.85 
325.037 Sm II 0 30757 0.94 0.15 -0.83 
324.446 Th I 0 
-
30813 0.56 0.09 -1.06 
324.987 Th I 0 
-
30762 0.48 0.08 -1 .12 
~ 
324.199 Ti II 0 30837 5.8 0. 91 -0.04 --~ 
I 324.153 Tm II 0 - 3084-l 1 • 1 0.17 -0.76 
325.805 Tm II 0 30684 0.87 0.14 -0.86 I = 
--
--
-
--
-
~ 
~ 
--
-
-
-
--
TABLE 1.3.1.2 
Ground State Lines Near the Zinc Line at 213.856 nm 
for Various Metals 
211.906 - 213.856 - 215.806 
Wavelength Metal 
nm 
213.856 Zn I 
214.438 Cd II 
211 .. 954 Ir I 
212.794 Ir I 
215.581 Ir I 
215.784 Os I 
214.423 Pt I 
215.667 Re I 
212.739 Sb I 
214.275 Te I 
212.672 Yb II 
Energy Level 
OK 
0 46745 
0 46619 
0 47165 
0 
-· 46979 
0 46372 
0 46328 
0 - 46622 
0 46353 
0 - 46991 
0 46653 
0 47006 
19 
106 
0.74 
2.1 
1 • 5 
1 • 1 
1 • 8 
1. 2 
0.43 
5.8 
0. 41 
1.3 
7.3 
0.05 
0 .. 14 
0.11 
0.08 
0.13 
0.08 
0.03 
0.40 
0.03 
18 
log gf 
0.12 
0.86 
-1.30 
-0.84 
-0.97 
-1.10 
-0 .. 90 
-
-
-1.80 = I . -1.53 
I 
-0.40 " 
-
-
-1.56 
-
~ 
~ 
~ 
.. 
-
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TABLE 1.3.1.3 
Metal Lines Which Can Overlap the Copper Line at 324.754 nm 
and the Zinc Line at 213.856 nm 
~ITa velength Metal Energy Level gA gf log gf 
-------------------~0. ---------~--g··~~--------------------~um -K- TU~-7 sec 
324.754 
324.755 
324.766 
324.747 
324.746 
213.856 
213.853 
Cu I 
Eu I 
Hf I 
Nb II 
Tm II 
Zn I 
Cu I 
0 
- 30784 4.1 
0 
- 30784 0.89 
2375 - 33139 0.67 
7901 - 38685 2.9 
8770 
- 39554 2.3 
0 - 46745 19 
11203 - 57949 0.51 
0.64 -0.19 
0.14 -0.85 
0.11 -0.98 
-
o. 46 -0.33 e i 
0.37 -0.43 ~ ~ 
I 
1.3 0.12 
0.04 -1.46.. 
-
I 
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TABLE 1.3.1.4 
Interference Absorbance by Various Metals at Copper and 
Zinc I'Tavelengths 
Metal, 1000 ppm Cu, Absorbance Zn, Absorbance 
a T24.754 nm at 213.856 nm 
Na 0.0000 0.0000 
K 0.0000 0.0000 
Li o.oooo 0.0000 
Ca o·.oooo 0.0000 
Mg 0.0000 0.0033 
Cr 
-0.0032 0.0000 
Ni 0.0033 0.0000 
Fe 0.0000 0.0000 
Mn 0.0000 0.0000 
Cu 0.0000 
Zn 0.0000 
e; 
i 
~ 
Ill 
~ 
-~ 
I 
I 
--
-
~ 
;;;; 
~ 
"" --
-
-
--
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1.3.2 Optical System 
TABLE 1.3.2.1 
Optical System for the Perkin-Elmer Model 303 Atomic 
Absorption Spectrometer 
Grating Czerny-Turner 
Dispersion uv 6.5 ~/mm 
Dispersion VIS 13.0 ~/mm 
Focal Length 400 mm 
uv Grating 2880 lines/mm -I 
i 
VIS Grating 1440 lines/mm ~ I! ; 
UV Blazed 2100 ~ 
VIS Blazed 6000 ~ 
Slit Openings 0.03 mm 
0.10 mm 
0.30 mm I 1.00 mm 3.00 mm -
-
10.00 mm 
~ -uv Spectral Band tvidth 0.2 -
"' VIS Spectral Band vlidth 0.4 R 
"' 
--
-
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TABLE 1.3.2.2 
Optical Slit Dimensions for the Perkin-Elmer Model 303 
Atomic Absorption Spectrometer 
Slit mm UV, R VIS, R UV, nm VIS, nm 
1 0.03 0.195 0.39 0. 01 9 5 0.039 
2 0.1 0 0.65 1 .3 0.065 0.13 
3 0.30 1.95 3.9 0.195 0.39 
4 1.0 6.5 13 0.65 1 • 3 
5 3.0 19.5 39 1.95 3.9 -5 
6 10.0 65 130 6.5 13.0 i ~ 
!l 
I 
I 
i 
"' 
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1. 3. 3 Flame Composition 
The conventional air-acetylene flame was chosen for the 
atomic absorption assay of copper. This flame is ideal for 
the analysis of copper since the flame does not have any 
significant absorbance at the convenient analytical 
wavelength of 324 •. 754 nm. The 2500°0 temperature of this 
flame is adequate for over 98 percent atomization of the 
copper(18). This atomization process for copper is not 
hindered by flame assisted compound formation, ionization, 
or wide variations in either the sample pH or the .fuel-air 
ratio. 
The nonconventional argon-hydrogen flame was chosen for 
the zinc atomic absorption analysis(19). In this system the 
argon replaces both the nebulizer air and the make-up air 
in the premix burner. The actual combustion occurs between 
the hydrogen and the air which surrounds the exterior of the 
burner head. There is no premixing of fuel and oxidant inside 
the premix burner chamber. 
The major advantage of the argon-hydrogen flame is the 
negligible 0.6 percent.absorption.at the analytical wavelength 
of 213.856 nm compared to the approximately 21 percent signal 
absorption at this wavelength by the air-acetylene flame(12). 
I 
I 
···---··--·--·~·-·-----
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Figure 1.3~3.1 is a plot of the percentage absorption by the 
flame versus wavelength for the air-acetylene and argon-
hydrogen flames. Greater precision and sensitivity are 
additional advantages obtained by the use of this flame 
system rather than the air-acetylene flame in zinc assays. 
argon-hydrogen flame. The results of the experiments in which 
potassium was added to cesium solutions imply that the 
argon-hydrogen flame temperature is considerably lower than 
the air-acetylene flame temperature since cesium is not 
ionized in this flame whereas in the air-acetylene flame it 
is 90 percent ionized(19). 
I 
I 
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FIGURE 1.3.3.1 
Percent Absorption ~ersus Wavelength for the Two Flames 
I 
I 
I 
90 ~ 
80 
~ 70 0 
•rl 
+> p.. 60 H 
0 
Ul 
..a 50 .. <tl 
'1:.~ 40 
30 
20 
10 
. 190 
!11!111111 JIII"IR!lilll!tlfl.lll~ll>ll .. 11 ,f,III.J.r:·IJII~IlllllniiiUII.II 
I Argon-Hydrogen Flame 
II Air-Acetylene Flame 
. 
;:'\__ I 
-200 210 220 
Wavelength, nm 
:m.111TIIIl1liiiii1Tllllllllllllntrnnm I 
l\.) 
0" 
27 
Burner Head and Nebulizer Selection 
A set of one ppm copper solutions was analyzed with 
single and triple slot burner heads and with old and new 
Perkin-Elmer nebulizers. Optimal results were obtained by the 
use of a triple slot burner head with the new nebulizer as 
our analytical work. 
TABLE 1 .3 .4.1 
Burner Head and Nebulizer Comparison 
Absorbance 
0. 019 
0.012 
o. 014 
0. 01 0 
%RSD 
3.2 
7.7 
9.5 
19.9 
n 
10 
10 
10 
1 0 
Burner Head 
Triple Slot 
Triple Slot 
Single Slot 
Single Slot 
Nebulizer 
New 
Old 
New 
Old 
28 
Burner Head Height Selection 
The burner height for atomic absorption is the distance 
in em that the top of the burner head lies below the bottom 
of the light path of the hollow cathode lamp. The burner 
------~h=e=2="ght with the largest burner height parameter(BHP) is the 
optimal burner height. A BHP is defined for a specified 
burner height as the product of the absorbance times the 
inverse of the %RSD for a set of data obtained under 
otherwise identical analytical conditions. 
Tables 1.3.5.1 and 1.3.5.2 give data for copper and 
zinc, respectively. The information in these tables provided 
the basis for the selection of a burner height of 1.5 em 
for copper and 4.0 em for zinc. 
I 
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TABLE 1.3.5.1 
Selection of the Burner Height for Copper Standard(2 ppm) 
Burner Height, em Absorbance %RSD. BHP n 
1.0 0.067 3.0 0.022 10 
1.5 0.065 2.7 0.024 10 
2.0 0.062 3.1 0.020 10 
2.5 0.063 3.7 0.017 10 
3.0 0.061 3.6 0.017 10 
3.5 0.060 4.9 0.012 10 
4 .. 0 0.057 3.5 0.016 10 
4.5 0.057 4.3 0.013 10 
5.0 0.055 5.1 0.011 10 
30 
TABLE 1.3.5.2 
Selection of the Burner Height for Zinc Standard(2 ppm) 
Burner Height~ em Absorbance %RSD BHP n 
1.0 0.056 3.7 0.015 10 
1.5 0.070 6.8 0.010 10 
2.0 0.073 3.6 0.020 20 
2.5 0.078 6 .. 1 0.013 10 
3.0 0.081 4.5 0.018 10 
3.5 0.081 4.7 0.017 10 
4.0 0.082 3.4 0.024 10 
4.5 0.077 4.4 0.018 10 
5.0 0 .. 073 7.4 0.010 10 
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1.3.6 Selection of the Fuel/Oxidant Ratio 
Two significant variables which are influenced by the 
fuel/oxidant ratio are the availability of electrons in the 
flame and the temperature of the flame. Electrons must be 
available to combine with gaseous metal ions to produce 
neutral metal atoms. Their availability is increased in fuel 
rich flames. The temperature of the flame influences the 
density of free neutral atoms at. the various electronic 
levels, the flame· velocity, and the ability of the flame to 
form and decompose various compounds in the flame. 
The selection of an·optimal fuel/oxidant ratio is 
actually a balancing of all variables.to obtain a maximal 
%RSD. The optimal ra.tio is. that ratio which results in a 
maximal value for the product of the absorbance times the 
inverse of the %RSD for a series of assays where only the 
fuel/oxidant ratio is varied •. Table 1.3.6.1 indicates 
that the optimal ratio for copper is obtained when the 
flowmeter scale in arbitrary units is 9.5 for acetylene 
and 9.0 for air. 
The fuel/oxidant ratio was not determined for the 
argon-hydrogen flame. In.this system the oxidant is the 
oxygen in the air that diffuses into the flame area from 
the atmosphere that surrounds the burner head. 
32 
Settings for the. flowmster scale,. in arbitrary units, of 
9.0 for argon and 5.0 for hydrogen \vere used for all 
zinc assays. 
TABLE 1.3.6.1 
Selection of the Fuel/Oxidant Ratio for Copper Standard(5 ppm) 
Flowmeter Scale in 
Arbitrary Units 
Acetylene Air Absorbance %RSD 
9.0 
9.5 
10.0 
10.5 
9.0 0.113 
9.0 0.113 
9.0 0.114 
9.0 0.109 
2.8 
. 2.0 
3.2 
5 •. 9 
Absorbance/%RSD 
0.040 
0.057 
0.036 
0.018 
n 
10 
10 
10 
1 0 
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1 .3 •. 7 Sample Injection Size 
The selection of an optimal sample injection volume 
requires compromises to be made 1vi t.h respect to an adequate 
absorbance value, a minimal %RSD, a sufficient volume of 
mouse plasma, and the number of required assays. 
r·ne sample volume or:. l5.Looa. avaJ.laolei'rom the various 
strains of mice without harm to the mice is in the range of 
50 to 200 l.IL. This will provide a plasma.volume of 25 to 
100 l.IL. That must be a sufficient volume for at least one 
assay for both copper and zinc. The available sample volume 
limits the injection size to a maximum of 25 uL. 
The optimal injection volume is that volume which 
results in a maximal value for the. product of the absorbance 
times the inverse of ths %RSD for a series of assays where 
only the injection volume is varied. Two series of assays 
were conducted with 2 ppm standard solutions of copper 
and zinc where only the injection volums was varied over 
the range of 1 to 10 l.IL. A separate series was conducted 
with a 1 ppm copper standard where only the injection 
volume was varied between 10 and 25 l.IL. 
I 
These results are listed in Table 1.3.7.3. An analysis of 
the combined results from the three tables suggests an 
injection volume of 10 ~1, as a compromise. 
TABLE 1.3.7.1 
Sample Injection Sizes for Copper Standard(2 ppm) 
34 
Volume, ~L Absorbance %RSD n (Absorbance/%RSD)/~L 
10 0.025 3.1 10 0.00081 
9 0. 022 . 6.2 10 0.00039 
8 0.020 3.6 10 0.00069 
7 0.018 5. 1 10 0.00050 
6 0.016 4.8 10 0.00056 
5 0.013 6.3 10 0.00041 
4 0.011 6.5 10 0.00042 
3 0.0080 10.7 10 0.00025 
2 0.0053 15.4 10 0.00017 
1 0.0020 27.6 10 0.00007 
35 
TABLE 1.3.7.2 
Sample Injection Sizes for Zinc Standard(2 ppm) 
Volume, ].lL Absorbance %RSD n (Absorbance/%RSD)/Jl1 
TABLE 1.3.7.3 
Large Sample Injection Sizes for Copper Standard(1 ppm) 
Volume, uL 
25 
10 
Absorban.ce %RSD 
0.048 12.5 
0.019 8.1 
n 
20 
20 
(Absorbance/%RSD)/Jl1 
0.00015 
0.00023 
I 
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1 .3. 8 Solvent Composition 
Several different mixtures of 6% organic solvents with 
water wer·e studied as aspiration solvents •. The basis for 
these studies was-literature reports of sensitivity 
enhancement by the use of organic solvent systems in atomic 
reported three- to fQur-fold increases in sensitivity. 
The sensitivity enhancement, is due to modification of 
solution-parameters. which result in the alteration of 
several dirferent nebul~zer and flame processes. The mixed 
organic-aqu~ous solvents, when compared to water, generally 
have a lowe~viscosity and surface tension~ These trends 
are simila~ to those found when organic solvents are compared 
with water. The advantages of mixed solvents a.re thus 
similar to the advantages of organic solvents but of a 
lesser· magnitude. A solution of lower viscosity and 
surface tension produces, via a. nebulizer, an aerosol with 
a smaller and more uniform .droplet size. As a result, a 
larger perdentage. of aerosol enters .the flame and is thus 
available for detection. The increased surface to volume 
ratio in the smaller droplets. results in the more rapid 
evaporation of solvent from a solvent aerosol ~olution 
of metal ions. 
This effect is desirable because .it provides additional 
residence time for the ion to absorb heat from the flame. 
37 
The ion thus attains a higher effective temperature which 
ultimately will result in a .larger percentage of neutral 
metal atoms in the flame. The organic solvent generally 
has a lower heat of vaporization. The requirement for less 
effect of increasing the flame temperature. It also has the 
undesirable effect of decreasing the cooling of the burner 
head and increasing the flame propagation velocity. These 
effects increase the likelihood of a flashback. 
The atomic absorption nebulizer can only nebulize 
.solutions. Therefore, the mixed solvent system must not 
cause precipitation of the mouse plasma sample. This 
requirement eliminates the use of pure organic solvents 
and any mixed organic-aqueous solutions with a high organic 
solvent concentration. 
Ketones, esters,. and alcohols have been reported to 
yield stable flames. Based upon the reported use of 6% 
n-butanol in water(21), the limited single phase solubility 
of many organic solvents in water,.and the plasma sample 
solubility requirementa a series of eight aqueous nebulizer 
solutions containing 6% organic solvent in water ~as tested. 
The results are presented in Table 1.3.8.1. The solvent 
of choice was 6% t-butanol in water. 
TABLE 1.3.8.1 
Solution Effects on Flame Copper Absorbance 
Solution, 6% 
in 1'later 
Copper, Absorbance(%RSD) 
5 ppm 2 ppm 1 ppm 0.5 ppm 
38 
n-propanol 0.0022(7.0) 0.0012(11) 0.00045(14) 
iso-propanol 0.011(18) 0~0045(19) 0.008(24) 
allyl alcob.ol Strong absorbance with a noisy flame 
ethyl acetate Strong absorbance with a noisy flame 
n-butanol 
iso-butanol 
sec-butanol 
t-butanol 
water(100%) 
0.017(5.6) 0.068(11) 
0.034(11) 
0.025(23) 
0.015(21) 0.005(25) 
Strong absorbance with a noisy flame 
0.078(8.8) 0.033(14) 0.014(13) 
0.046(8.5) 0.019(18) 0.008(29) 
--------------------------
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1.3.9 Solvent Flow 
The rate with which the. injected sample and the 6%(v/v) 
t-butanol· solvent are pumped into the nebulizer determines 
the amount of sample· in the light path and thus the magnitude 
of the absorbance signal and the precision of·that signal. 
----'.~;+'-1n:;-:r"''-o--w-rrl-e-o-£'-6-%c-t-bu-tcrrm-t-in t~th e n e buri z e r is set by 
adjusting the helium pressure on the solvent pressure 
reservoir. A calibration curve of helium reservoir pressure 
versus flow rate is presented in Table 1.3.9.1 and Figure 
1.3.9.1 .. 
In order to determine the optimal flow rate for the 
analysis of copper and zinc, a set of 5 ppm zinc standards 
was analyzed under fixed experimental conditions at various 
flow rates. The zinc absorbances at the.various flow rates 
were determined at 213.856 nm. The results of this experiment 
are listed in Table 1.3.9.2. The optimal flow rate of 6% 
t-butanol has a maximal value of the product of the absorbance 
times the inverse of the %RSD~ Figures.1.3.9.2 and 1.3.9.3 
are graphs of the zinc absorbance versus flow rate and the 
%RSD versus flow rate, respectively, for this experiment. 
The optimal flow rate of 6% t-butanol for the assay of zinc 
is 1.0 mL/min. This flow rate is an optimum since lower 
solvent flow rates will result in excessive burner head 
temperatures. 
40 
A se-t of 2 ppm.copper .standards was analyzed under 
fixed experimental conditions at va.rious flow rates. The 
copper absorbances at the various flow~rates were determined 
at 324.754 nm .. The results of this experiment are listed 
in Table 1.3.9.3. The optimal flow rate of 6% t-butanol for 
the assay of copper is determined from the experimental data 
by selecting the maximal value from the calculation of the 
product of the absorbance times the inverse.of the %RSD. 
Figures 1.3.9.4 and 1.3.9.5 are graphs of the copper 
absorbance versus flow rate and the %RSD versus flow rate, 
respectively, for this experiment. The optimal flow rate 
of 6% t-butanol for the assay of copper is 2.5 mL/min. 
' 
. I 
TABLE 1.3.9.1 
Pressure in the Helium Reservoir. versus Flow Rate 
Helium. 
psi 
8 
14 
20 
30 
40 
50 
Volume, 
mL 
3.0 
3.0 
5.0 
7.0 
7 .. 0 
8.0 
Time,. 
min 
3.04 
1. 78 
1.97 
1. 79 
1.32 
1 .1 8 
Flow·Rate, 
mL/min 
1 • 0 
1 • 7 
2.5 
3.9 
5.3 
6.8 
41 
-------------~------·-
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TABLE 1.3.9.2 
Zinc Absorbance and %RSD versus Flow Rate 
Helium, 
psi 
8 
14 
20 
30 
40 
50 
Flow Rate, Absorbance, %RSD Absorbance/%RSD 
mL/min Zn 
1 • 0 0.077 4.1 0.019 
1.7 0.070 4.0 0.018 
2.5 0.065 4.7 0.014 
3.9 0.052 4.2 0.012 
5.3 0.043 4.1 0.010 
6.8 0.034 4.1 0.008 
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TABLE 1 .. 3.9.3 
Copper Absorbance and %RSD versus Flow Rate 
Helium, 
psi 
8 
14 
20 
30 
40 
50 
Flow Rate, Absorbance, %RSD Absorbance/%RSD 
mL/min Cu 
1.0 0.064. 1 3.1 0.005 
1. 7 0.066 7.9 0.008 
2.5 0 •. 073 2.9 0.025 
3.9 0.055 3.7 0.015 
5.3 0 .04.6 4.7 0.010 
6 .. 8 0. 040. 9 •. 6 0.004 
------------- --,-------~--
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FIGURE 1.3.9.1 
Pressure in the Helium Reservoir versus Flow Rate 
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FIGURE 1.3.9.2 
Zinc Absorbance versus Flow Rate 
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FIGURE 1.3.9.3 
Zinc %RSD versus Flow Rate 
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FIGURE 1.3.9.4 
Copper Absorbance versus Flow Rate 
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FIGURE 1.3.9.5 
Copper %RSD versus Flow Rate 
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1.3.10 Hatrix Matching of Standard Solutions 
The copper and zinc concentrations in the mouse plasma 
samples were calculate·d from the absorbance data by a linear 
least squares method based upon calibration with agueous 
copper and zinc standards. The validity of this use of 
a:q-u--e-o--u-s-nre-t-a:-1-----s--tandard sol:ut-ions for "Ghe determinat-ion oi" 
concentrations of metals in very complicated sample matrices 
such as mouse plasma was established. by a very extensive 
series of experiments involving copper and zinc aqueous and 
matrix matched standards and additions of such standards to 
pooled human plasma. 
The standard curvea, standards~ and results are presented 
in the following tables and figures. 
TABLE FIGURE 
1.3.10.1 1.3.10.1 Matrix Matched Copper Standards 
1.3.10.2 1.3.10.2 Standard 4dditions of Aqueous Copper 
Standards to Pooled Human Plasma 
1.3.10.3 1.3.10.3 Standard Additions of Matrix Matched 
Copper Standards to Pooled Human Plasma 
55 
1.3.10.4 1.3.10.4 .Matrix Matched.Zinc Standards 
1.3.10.5 1.3.10.5 Standard Additions of Aqueous Zinc 
Standards. to. Pooled Human Plasma 
1.3.10.6 1.3.10.6 Standard Additions of Matrix Matched 
1.3.10.7 
1.3.10.9 
Zinc Standards to Pooled Human Plasma 
Copper and Zinc Standard Solutions 
in Pooled Human Plasma 
Slopes of Aqueous and Matrix Matched 
Standard Curves 
The matrix matched standards consisted of the metal 
ion at the appropriate concentration, 0.15 M NaCl, and 6% 
Dextran(173,000 M~v, Sigma.). (20,22). The experiments 
consisted of obtaining the standard curves for. the aqueous 
and matrix matched standards and. the human plasma standard 
additions curves for the aqueous and matrix matched 
standards which had been added to the pooled human plasma. 
A comparison of the slopes of the various graphs is 
presented in Table 1.3.10.9. 
The slope of~an ideal matrix matched.standard will be 
the same as the slope of a matrix matched standard additions 
ctirve. The matrix match is considered .to be adequate when 
the slopes yield results that are, within tha precision of 
the measurement, statisti.cally indistinguishable. 
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This is the case for t.he aqu.eous zinc standards and the 
aqueous or· the ma·tri.x matched additions to the pooled human 
plasma. The matrix matched zinc standards will. yield results 
that are approximately 20% high. Th.e .vali.dity of the use of 
aqueous copper standards is questionable. The use of matrix 
____ _.,m""a.._,t ch_e_d_c op_p__e_r_____s_tan dards i_s_p_r_e_f_ar.r_e_d_._T_b._e_a_q u eo us co p_p er~----­
standards, however, produce results that are less than 5% 
high. This is well within the 10% RSD precision criteria 
at the 1 ppm level. Agueous standards were used for the 
determ~nation of copper and zinc in. mouse plasma. 
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TABLE 1 • 3. 1 0. 1 
Matrix Matched Copper Standards 
Solution # Cu, ppm Absorbance Standard Dev~ation %RSD n 
'3 
10 
11 
12 
5---;-0-o 
2.00 
1 .oo 
0.50 
o--;--o--54:; 
0.0248 
0.011 0 
0.0068 
Linear Least Squares 
n = 4 
Correlation = 0.9980 
Slope = 0. 01 06 
X = 0, y = 0. 0016 
y = 0, X = -0.1507 
0. OOl-9 
0.0012 
0. 0012 
0.0006 
3.5 9 
4. 9 10 
11.1 10 
9.3 9 
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Matrix Matched Copper Standards 
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TABLE 1.3.10.2 
Standard Additions of Aqueous Copper 
Standards to Pooled Human Plasma 
60 
Solution # Cu, Absorbance Standard Deviation %RSD n 
ppm 
( 1 '1 4) o.oo 0.0090 0.0011 12.6 10 
( 3' 1 4) 0.50 0. 01 52 0.0008 5.1 10 
( 5' 14) 0.99 0.0201 0.0010 5.0 10 
( 7,1 4) 1.96 0.0300 0.0017 5.6 10 
( 9, 14) 4.76 0.0621 0.0013 2.0 10 
Linear Least Squares 
n = 5 
Correlation = 0.9997 
Slope = 0.0111 
X = 0, y = 0.0091 
y = 0, X = -0.82 
FIGURE 1.3.10.2 
Standard Additions of Aqueous Copper 
Standards to Pooled Human Plasma 
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TABLE 1.3.10.3 
Standard Additions of Matrix Matched Copper 
Standards to Pooled. Human Plasma 
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Solution # Cu, Absorbance Standard Deviation %RSD n 
ppm 
(1,16) o.oo 0.0077 0.0012 15.6 10 
(3,16) 0.50 0.0146 0.0011 7.5 10 
(5,16) 0.99 0.0194 0.0008 4.0 10 
( 7,16) 1.96 0.0317 0.0009 3.0 10 
(9,16) 4.76 0~0605 0.0012 2.0 10 
Linear Least Squares 
n = 5 
Correlation = 0.9990 
Slope = 0.0110 
X= 0, y = 0.0087 
y = 0, X = -0.79 
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_____________ __,_,.FIGURE 1 .3~.j_0~._3) ______________ _ 
Sta~dard Additions of Matrix Matched Copper 
Standards to Pooled Hu~an Plasma 
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TABLE 1.3.10.4 
Matrix Matched Zinc Standards 
Solution # Zn, ppm Absorbance Standard Deviation %RSD n 
1 ~ 5-.-0-0 0-.-0Jf-JJ 0--0-0-62 7-3-1-0 '7 
14 2.00 0.0531 0.0034 6.3 10 
15 1.00 0.0316 0. 0041 1 3. 0 1 0 
16 0.50 0. 01 95 0.0018 9.2 10 
Linear Least Squares. 
n = 3 
Correlation = 0.9996 
Slope = 0.0223 
X = 0, y = 0.0087 
y = 0, X = -0.39 
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FIGURE 1.3.10.4 
Matrix Matched Zinc Standards 
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TABLE 1.3.10.5 
Standard Additions of Aqueous Zinc 
Standards to Pooled Human Plasma 
69 
Solution # Zn~ ppm Absorbance Standard Deviation %RSD n 
(1,11) o.oo 0. 0321 0.0034 1 o. 7 1 0 
(3,11) 0.50 0.0449 0. 0021 4.6 10 
(5,11) 0.99 0.0535 0.0051 9.6 10 
(7,11) 1.96 0.0709 0.0047 6.6 1 0 
(9,11) 4.76 0.1034 0.0037 3.5 1 0 
Linear Least Squares 
n = 4 
Correlation = 0.9963 
Slope = 0. 01 94 
X = 0, y = 0.0336 
y = 0, X = -1.70 
-------------- -----------
FIGURE 1.3.10.5 
Standard Additions of Aqueous Zinc 
Standards to Pooled Human Plasma 
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TABLE 1.3.10.6 
Standard Additions of Matrix Matched Zinc 
Standards to Pooled Human Plasma 
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Solution # Zn, ppm Absorbance Standard Deviation %RSD n 
(1,13) o.oo 0. 031 7 0.0026 8.3 9 
(3,13) 0.50 0.0452 0.0043 9.5 1 0 
(5,13) 0.99 0.0558 0.0047 8.4 1 0 
(7,13) 1.96 0.0714 0 .. 0049 6.9 10 
(9,13) 4.76 0.1 011 0 •. 0039 3.9 10 
Linear Least Squares 
n = 4 
Correlation = 0.9918 
Slope = 0. 01 99 
X = 0, y = 0.0338 
y = 0, X = -1.70 
FIGURE 1.3.10.6 
Standard Additions of Matrix Matched Zinc 
Standards to Pooled.Human Plasma 
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TABLE 1.3.10.7 
Copper and Zinc Standard Solutions 
Solution # Cu, ppm Zn, ppm . NaCl, M Dextran, %(v/v) 
1 5-~-0D 
2 2.00 
3 1.00 
4 0.50 
5 5.00 
6 2.00 
7 1.00 
8 0.50 
9 5.00 0.1 5 6 
10 2.00 0.15 6 
11 1.00 0.1 5 6 
12 0.50 0 .. 15 6 
13 5.00 0.1 5 6 
14 2.00 0.1 5 6 
15 1. 00 0.1 5 6 
16 0.50 0.15 6 
76 
TABLE 1.3.10.8 
Copper and Zin.c Standard Solutions 
ih Pooled Human Plasma 
Solution # Cu, ppm Zn, ppm Added NaCl Added Dextran 
--------------------------------~~x~~-3M ____ ~v~~vJ. ____________ _ 
(1,11) o.oo 
(3,11) 0.50 
(5,11) 0.99 
(7,11) 1.96 
(9,11) 4.76 
(1,13) o.oo o.oo o.oo 
(3,13) 0. 50. 0.75 0.03 
(5,13) 0.99 1 .49 0 •. 06 
(7,13) 1.96 2.94 0.12 
(9,13) 4.76 7.14 0.29 
(1 ,14) o.oo 
(3,14) 0.50 
( 5, 14) 0.99 
(7,14) 1.96 
( 9,1 4) 4.76 
TABLE 1.3.10~8 (CONTINUED) 
Solution # Cu, ppm Zn, ppm Added NaCI 
X 10-JM 
(1.16) o.oo O_~_QO 
(3,16) 0.50 0.75 
(5,16) 0.99 1 .49 
(7,16) 1.96 2.94 
(9,.16) 4.76 7.14 
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Added Dextran 
%(v/v) 
0-~-0D 
0.03 
0.06 
0.12 
0.29 
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TABLE 1.3.10.9 
Slopes of Aqueous and Matrix Matched Standard Curves 
Table Slope Metal Standard 
1 .--§-.~ n n1?(... ....,-.. -9-.-.....--li;l G-ll A,..,,, of"\,, o :.n;c:r~-'-'-\;n;;;&.~...., 
1.3.10.1 0. 01 06 Cu Matrix Matched 
1.3.10.2 0.0111 Cu Aqueous Additions, Plasma 
1.3.10.3 0.011 0 Cu Matrix Additions, Plasma 
1.5.2 0.0198 Zn Aqueous 
1.3.10.4 0.0223 Zn Matrix Matched 
1.3.10 • .5 0.0194 Zn Aqueous Additions, Plasma 
1.3 .. 10.6 0.0199 Zn Matrix Additions, Plasma 
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1.4 Instrumental Parameters for Atomic Absorption 
A summary of the instrumental parameters for atomic 
absorption as developed in section 1.3 is given in Table 
1.4.1. These flow injection analysis system parameters 
were used for the assay of copper and zinc in mouse plasma 
with the Perkin-Elmer Model 303 atomic absorption 
spectrometer. 
TABLE 1.4.1 
Instrumental Parameters for Atomic Absorption 
Parameter 
Wavelengt 
Recorder Chart Speed 
Recorder mv 
Recorder Readout Noise 
Recorder Readout Scale 
Slit 
Helium Pressure on the 
Solvent Reservoir 
Copper 
]24-;-T54 nm 
1 em/min 
20 mv 
2x 
30x 
4 
20 psi 
Solvent Flow Rate 2.5 mL/min 
Flow Injection Analysis 6%(v/v) t-butanol 
Solvent in Water 
Burner Head Type Triple Slot 
Burner Lead Head Screw. 1.75 
Turns ccw 
Burner Height 
Fuel Flow 
Oxidant Flow 
Injection Size 
-1.5 em 
9.5(C 2H2 ) 
9.5(Air) 
1 o uL 
80 
Zinc 
:,zry;-s-5-6 nm 
1 em/min 
50 mv 
2x 
30x 
5 
8 psi 
1.0 mL/min 
6%(v/v) t-butanol 
in Water 
Triple Slot 
1.75 
-4.0 em 
5.0(H2) 
9.0(Argon) 
1 o uL 
1.5 Standard Calibration Curves for Copper and Zinc 
Cu, ppm 
5.00 
2.00 
1.00 
0.50 
TABLE 1 .5.1 
Absorbance of Aqueous Copper Standards 
Absorbance Standard Deviation %RSD 
0.0627 
0.0252 
0.0123 
0.0062 
0.0013 
0.0007 
0.0008 
0.0009 
2.1 
2.8 
6.6 
15.2 
Linear Least Squares 
n - 4 
Correlation. = 1.0000 
Slope = 0.0126 
X = 0, y = -0.0001 
y = 0, X = 0.0090 
n 
11 
10 
1 0 
10 
81 
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FIGURE 1.5.1 
Absorbance versus Concentration of Copper Standards 
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5 6 
Zn, ppm 
5~0 
2.00 
1.00 
0.50 
TABLE 1.5.2 
Absorbance of Aqueous Zinc Standards 
Absorbance Standard Deviation %RSD n 
0.0859 
0.0464 
0.0273 
0. 0165 
0.0028 
0.0029 
0.0018 
0.0011 
3.3 10 
6.3 10 
6.6 10 
6.6 10 
Linear Least Squares 
n = 3 
Correlation = 0.9994 
Slope = 0.0198 
X = 0, y = 0.0069 
y = 0, X = -0.3499 
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Absorbance versus Concentration of Zinc Standards 
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0 
1 2 3 4 5 6 
Zinc, ppm 
1.6 
1 • 6.1 
Data Analysis Programs and Procedures 
Program to Calculate Absorbance Values from 
Peak Height 
The Perkin-Elmer Model 303 atomic absorption 
87 
··-·· --------
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The problem which arises under the 100 mm boundary 
condition is that we are restricted to only using a 100 mm 
section of a 250 mm wide chart paper. The decision was to 
use the full width of the chart paper by adopting a 1000 mm 
boundary condition. The following program was used to 
convert peak heights in mm to absorbance with the boundary 
This program is written for a Texas Instruments Hodel 55 
(TI-55) calculator. It is based upon the formula of 
Absorbance= -log10 ((1000 - mm ) I 1000 ). 
2nd CA 2nd Fix 6 2nd Lrn i + 1000 = · 1000 = 2nd log = 
+ = 2nd RIS 2nd Rst 2nd Lrn 2nd Rst 
An earlier equivalent formula.and its corresponding program 
is Absorbance =- log10 (( 100 - ( mm x 10-
1 )) I 100 ). 
2nd CA 2nd Fix 6 2nd Lrn x ( 1 i 2nd 10x ) = i + 100 = 
+ 100 = 2nd log = ± = 2nd RIS 2nd Rst 2nd Lrn 2nd Rst 
Program verification: 
To determine the absorbance of a peak height in mm, 
do the following: 
1 • 
2. 
Enter the height in mm 
Push 2nd 
Push R/S 
ex: 14.5 ex: 18.5 
89 
3. 
4. The register will read 0.006343 0.008110 
1.6.2 
----------~~~~~~~~~-
Program to Calculate Absorbance Values from 
Absorption Values 
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The following program was written for a TI - 55 
calculator. The program permits the calculation of absorbance 
values from absorption values. An absorption value of 1.0000 
is 100 percent absorption. The program is based upon the 
formula of absorbance = log10 ( 1 -absorption ). 
2nd CA 2nd Fix 4 2nd Lrn = ~ + 1 = 2nd log = + = 
2nd R/S 2nd Rst 2nd Lrn 2nd Rst 
Program verification: 
To determine the absorbance from an absorption value, 
do the following: 
1. 
2. 
3. 
4. 
Enter the absorption value 
Push 2nd 
Push R/S 
The register will now read 
ex: 0.4268 ex: 0.5000 
0.2417 0.3010 
1 • 6. 3 Program to Calculate Peak Heights from 
Absorbance Values 
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The following program was written for a TI - 55 
calculator. The program permits the back calculation of peak 
heights in mm from previously calculated absorbance(A) 
values wnere tnose aosorl5ance va..Lues were calcu.lated oy tne 
formula of absorbance= - lo~10 (( 1000 ~ mm )/ 1000). The 
boundary condition is that 1000 mm of peak height is equal 
to 100 percent absorption. The ~rogram is based upon the 
formula of mm = ((( 1000 x 10A ) - 1000 )/ 10A ). 
2nd CA 2nd Fix 0 2nd. Lrn STO 1 RCL 1 2nd 10x x 1000 = 
- 1000 = ) ~ ( RCL 1 2nd 10x ) = 2nd R/S 2nd Rst 
.. 
2nd Lrn 2nd Rst 
Program verification: 
To determine the peak height in mm from a previously 
calculated absorbance value~ do the following: 
1. Enter the absorbance value ex: 0.068542 ex: 0.004804 
2.. Push 2nd 
3 •· 
4. 
Push R/S 
The register will now read 146 11 
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Procedures .and. Criteria. for Data Analysis 
The primary atomic absorption data from the experiments 
consisted of narrow peaks on stripchar.t recording paper. The 
height of each individual peak was determined with a metric 
ruler to the nearest mm. This height represents and is 
proportional to the size of the instrument absorption signal. 
An absorbance value was calculated from this peak height. 
The boundary condition in the calculation was that 1000 mm of 
peak height is equal to 10Q percent absorption. 
A~· .. linear least squares standar·d curve was prepared from 
the calculated absorbance values for the aqueous standards. 
Each standard w~s injected ap~roximately ten times. Standards 
were injected at the beginning of every analysis session. 
The calculated absorbance values for the mouse plasma samples 
were then entered into the calculator •. The concentration of 
the metal in ppm was determined from standard curves 
previously developed by a linear least. squares method. A 
typical analysis run consisted. of a series of four standards 
of the metal of interest and. approximately fifty plasma 
samples. The total number of.inject1ons in a typical run was 
approximately ninety. 
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Data of questionable.quality were individually 
rejected £rom the set of data when they fell outside of the 
4Q criterium which requires the removal of data points that 
are away· from the mean. by more than four times the standard 
deviation. The mean and the standard deviation about the mean 
are calculated from the set of data remaining after the 
a.atum point in question has been removed-;-Data not obtained 
under the specified instrumental parameters, particularily 
the requirement for 10 ~L of sample, were also removed. 
CHAPTER TWO 
2. Audiogenic Seizure Susceptible Mouse Model of Epilepsy 
The analytical methods that were developed in Chapter 
One have been applied to an epilepsy project •. That project, 
which involves the use of audio.gen.ic sei·zure susceptible 
mice, is introduced. in this chapter. 
Epilepsy is a "recurrent sel.f-sustained. paroxysmal 
disorder o£ brain function characterized by excessive 
discharge o.f cerebral. neurons 11 ( 2.3). The. frequency of 
epilepsy in the human population is approximately 0.5 
percent (24). Since the causes of epilepsy are as varied 
as the clinical expressions we prefer to view the 
manifestations of epilepsy as a symptom of one or more 
disease states. 
Historically, epilepsy has long been recognized as a 
disease state in such documents as the Code of Hammurabi 
who set rules regardingthe marriage of epileptics and the 
admissibility of their court testimony ( 24) •. Hippocrates 
considered epilepsy a disease of.the brain (24). 
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Charles le Pois.was the first. to state that all 
epileps~es- originate in the brain (24). Jackson introduced 
the idea of a discharging focus when he explained seizures 
as the reBult of paroxysmal discharges beginning at and 
spreading from a focus location. in the brain (24). Berger 
introduced electroencephalography(EEG) (24). This technique 
i--s-t"11e recor·<i-ing of-tne mil-rivolt potential of an epileptic 
discharge on a millisecond time scale. Such techniques make 
it possible to locate and characterize the epileptic 
discharge and also to develop and verify experimental 
models of human epilepsy by comparison of the resulting 
EEG seizure patterns. 
Numerous models of human epilepsy have been developed 
and verified by EEG techniq.u.es for purposes of testing 
anticonvulsant drugs and studying t.he underlying chemistry 
of the epileptic disease state. A "model" of human epilepsy 
consists of a procedure applied. to a certain animal or 
tissu:e. Models of human epilepsy which have been developed 
for the purpose of testing anticonvulsant drugs consist of 
procedures 'tvhich involve the topical application of 
convulsant metals to neural tissue, freezing of a localized 
section of brain, administration of convulsant drugs to 
mammals, electrical stimulation of neural tissue, and 
disturbances of metabolic equilibria. 
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Models of human epilepsy which ha.ve been. developed for the 
purpose of studying the underlying chemistry of the disease 
state consist of applications of the previously listed 
procedures, the application of. those procedures to humans 
and other genetically seizure susceptible mammals, and 
procedures which involve the chemistry of genetically 
seizure susceptible mammals. These mammals are certain 
strains of goats, Senegal baboons, mice, rats, and rabbits 
(23, 25-30). All of these animals are susceptible to drug 
induced seizures. They are also susceptible to seizures 
which have been initiated by rather rare methods~ Certain 
strains of Senegal baboons are seizure susceptible to 
intermittent light stimulation. S~lected populations and 
strains of rabbits, rats, and mice are susceptible to audio-
genic seizures. The advantages of low cost, availability of 
many different inbred strains,. rapid reproductive rates, 
and the superb genetic definition obtained as a result of 
hundreds of generations of inbreeding has resulted in the 
establishment and widespread acceptance of the audiogenic 
seizure susceptible mouse model of epilepsy (28). 
This model of epilepsy has two important experimental 
parameters. The first is that the percentage seizure 
susceptibility of mice is age dependent. 
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Vicari extablished the bimodal age dependence of the DBA/2 
strain (31). Table 2.1 presents her results for the percent 
of DBA/2 mice by age that will convulse on the first trial 
within 90 seconds after sound initiation £rom an 80 to 90 db 
electric hell in a metal tub. She obtained a maximum of 
90 percent seizure susceptibility for DBA/2 mice in the 
30-34 day .. age group and a second maximum o:f 25 percent in 
the 60-69 day age group. Not all strains of.seizure 
susceptible .mice exhibit a bimodal susceptibility curve 
but they do have· a curve, that generally shows seizure 
susceptibili.ty beginning aroblnd day 14, peaking in the 
30 1 s,. and then declining (32,33). 
The s:eeond. important experimental parameter is that 
audiogenic se-izure susceptibility varie.s widely among various 
inbred strains •. Fuller and Sjursen. ha.ve ranked the seizure 
susceptibility of eleven strains of inbred mice (34), in the 
order DBA/2J > LP/J > 129/J > .RF/J. > AKR/J .> LG/J > SJL/J > 
CBA/J > SM/J > BALB/cJ > C5?BL/6J. We obtained a similar but 
slightly different ranking.of six of their strains by 
converting their graphical data into percentage seizure 
susceptibility by week,. obtaining the average of the seizure 
susceptibility over the weeks 3,4,5, and 6 and ranking the 
six selected strains in the order of percentage seizure 
susceptibility. 
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TABLE 2.1 
BDA/2 Mouse Age versus Percent Seizure Susceptibility 
Mouse Age~ Days Percent Seizure Susceptibility 
10-19 0 
20-24 60 
25-29 88 
30-34 90 
35-39 80 
40-44 61 
45-49 66 ' 
50-59 7 
60-69 25 
70-79 17 
80-89 0 
90-99 0 
100-600 0 
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The result is the slightly modified percentage seizure 
~usceptibility order o£ LP/~(~7%) > DBA/2J(94%) > SJL/J(70%) > 
LG/J(65%) > BALB/cJ(24%) > C57BL/6J(14%). The combination 
of age variation and interstrain variation in seizure 
susceptibility allows the design of experiments showing the 
presence or absence of correlation between a measurable 
parameter and seizure susceptibility. 
The transmission of seizure susceptibility from a 
seizure susceptible mouse to a non-seizure susceptible mouse 
by connecting their circulatory systems by surgical 
parabiotic union was demonstrated .by Hamburgh(J5). This 
experiment established the influence of some unknown 
aspect of the circulatory system such as the presence, 
absence, or a concentration change in a chemical upon 
seizure susceptibility. The experiment suggests that there 
exist significant chemical. differences between the 
circulating fluids of susceptible and resistant mice. 
The large number of metalloenzymes that contain copper 
and zinc, their influence.in numerous metabolic pathways, 
the 25 to 40 percent elevation of copper and the 20 percent 
reduction of zinc in the serum of human epileptics receiving 
anticonvulsant medication, and the lack of data for copper 
and zinc plasma concentrations as a function of age for 
epileptic mice, led to considering this. res.earch project 
( J 6 ,3 7 , J 8 ) • 
------·-·-·· ------ -·· ---~------~--
The project was to_ determine the. plasma copper and zinc 
concentrations by age. for the previously described series 
100 
of six selected strains of audiogenic .sei~ure susceptible 
mice, to compare the results with thei~ age and strain 
dependent audiogenic seizure susceptibility,. and to determine 
of the mice and their plasma copper and/or zinc concentrations. 
The experiments required repeated measurements of 
coppe~ and zinc concentrations in 10 ~1 samples of mouse 
plasma with adequate precision at the one p.pm level. This 
resulted in the extensive development of atomic absorption 
flow injection techniques to obtain the required accuracy 
and precision. For the nscessary observation of a 20 percent 
change in zinc concentration, an analytical precision of 
10 percent at the one ppm level was considered appropriate. 
CHAPTER THREE 
3. Experimental 
3.1 Animal Husbandry 
3.1.1 Mouse Cages and Racks 
Six strains of non-pedigree littermate breeder mice 
were obtained from The Jackson Laboratory, Bar Harbor, Maine. 
The strains were C57BL/6J,. LG/J, DBA/2J, SJL/J, BALB/cJ, and 
LP/J. They were housed, one breeding pair per cage, in two 
cage racks of 36 cages per rack. Each cage rack held six 
rows of six cages per row. The mice were segregated to one 
strain per column in the previously listed order. Cages 
were numbered by column starting with row one. 
3.1.2 Mouse ~va ter 
Tap water, acidified w.ith five drops of concentrated 
HCl per 500 mL was available.to the mice on an ad lib basis. 
This level of acidification is recommended as a means of 
reducing microbiG.>lo.gical. growth in. the water bottles(39). 
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It also reduces the deposition of calcium and other minerals 
on the insides of the water bottles. The pH of the water was 
determined to be 2.58 with a. standard deviation of 0.02. 
3.1.3 Mouse Diet 
~-------iM-o-u.-s-e~~e-e-d~e~f-t-h-e~s-¥-e-e-i-f-i-e-t-y-p-e-s-a-s-1-i-s-t-e-d-±-n-T-a-b-J:-e------
3.1.3.1 was available to the mice on an ad lib basis., We 
note that the DBA/2J mice were very poor breeders when the 
diet contained more than 6% fat. Other mice such as the 
BALB/cJ are poor breeders unless the diet contains at least 
10% fat~ The diets were chosen on the basis of published 
Jackson Laboratory r.ecommenda tions, breeding experience 
in our laboratory, availabil£ty, and price (40). 
C57BL/6J 
LG/J 
DBA/2J 
TABLE 3.1.3.1 
Diets 
Purina Lab Choiv 
X 
X 
X 
911A 
X 
X 
961vA 
X 
SJL/J 
BALB/cJ 
LP/J 
Purina Lab Chow 
X 
911 A 
X 
X 
X 
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96vlA 
The first row of v~lues in Table 3.1.3.2 are provided 
by the Ralston Purina Co. These values are typical Purina 
Lab Chow lot analysis test results •. The Old Guilford Lab 
Diet values fo.r the 911A and 96Tt>TA are published Jackson 
Laboratory specifications (40). 
Diet 
Purina Lab Chow 
911A 
96WA 
TABLE 3.1.3.2 
Diet Composition 
%Fat 
4.5 
10.-3 
7.5 
%Protein %Fiber 
23.0 6.0 
20 •. 1 2.6 
22.5 2.3 
%Ash 
8.0 
4.9 
4.5 
3.1 .4 House Bedding 
Mouse bedding cons~sted of either autoclaved wood 
shavings or pelletized and autoclaved sawdust pellets. 
3.1. 5 Cage Cleaning 
Mouse cages and water bottles were washed, cleaned, 
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and recharged with. new beddin.g, water, and food approximately 
once every ten days. 
3.1. 6 Mouse Room Environment 
The cage racks were located in a working research 
laboratory on either side of a dual bank of continuously 
operating laboratory fume hoods. The hoods provided a 
constant low background noise and a room air change 
approximately one every three minutes. The laboratory 
temperature was approximately 20 °C. The cool white 
fluorescent lighting was not on timers but was off 
approximately six to eight hours every night. We were aware 
of reports of environmental influences on. the health of 
laboratory·animals(41). The 6lean, calm, and consistent 
laboratory environment resulted in a healthy mouse colony. 
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3.1.7 Evolving Number System 
Sufficient data were maintained on the date of births, 
cage transfers, age of weaning, pairings, and deaths by the 
use of weekly cage "Transfer Sheets" to permit the 
calculation of individual mouse numbers by the evolving 
number method(42) .• This system was used during the first 
year of the colony but was dropped due to the large time 
requirements for its maintenance with a colony that consisted 
of 60 breeding pairs and a total population of approximately 
300 mice. At ~ach cage:cleaning a total count was maintained 
for all mice by location, sex, strain, and breeding or 
experimental status. 
3.1. 8 Mouse Plasma 
The following procedure for obtaining mouse plasma 
was developed as the result of a considerable amount of 
experimentation with numerous. widely. different methods and 
procedure&. ·The procedure described here requires a total 
collection time of approximately five minutes per mouse 
for all collection and preparation steps. . 
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One begins by .Placing the mouse in a "mouse vise" with 
the tail held outside of tha apparatus. It is necessary to 
firmly hold the end of the tail at all times. The tail is 
closely shaved with a disposable razor. A prominent tail 
vein, usually the dorsal vein, is then sliced with a scalpel 
about 2 em from the posterior in a. direction. perpendicular to 
the long axis of the vein. A 250 mm heparinized haematocrit 
tube is placed in such a manner that it .just touches the 
drop of blood that forms at the vein cut. The goal is to 
collect as much blood as .possible in the haematocrit tube. 
The collected whole blood. is then blown out of the tube and 
into a 400 uL microcentrifuge tu~s. This tube:is centrifuged 
at 4000 rpm for fifteen minutes. The upper plasma layer is 
removed with a 20 uL Eppendorf micropipet and placed in a 
250 uL microcentrifuge tube. This .tube, made of conventional 
polyethylene, is capped and placed in a known location on 
the grid of a plasma sample board. 
Plasma was analyzed rather· than serum because experimen-
tation was easier and the· difficulty o.f reproduci.bly 
clotting ~mall volumes of. whole blood was avoided. The 
analytical procedure requires at least 50 uL of whole blood 
prior to the centrifuge step. 
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This resul·ts. in at .least 25 'IlL of plasma for analysis thus 
allowing 10 uL per metal and 5 uL for sdlution volume. It 
is rather difficult to consistently and readily obtain 
such volumes· of. whole. blood fro.m. small young mice. 
Records of plasma collection were maintained on a 
"Blood Collection Sheet". These data consist of the mouse 
cage number. strain, sex, time of collection, date of 
collection. volume of whole blood collected, and the final 
grid location on the plasma samp.le board. The plasma 
sample board was a rectangular board with a grid network 
of holes drilled into its surface. Each hole holds a 
250 11L conventional polyethylene.microcentrifuge tube. 
3.2 Miscellaneous Experimental Details 
3.2.1 Water 
All water used in all experiments was deionized, 
filtered through·a 0.4511 Millip.ore filt.er,. doubly distilled, 
and stored in linear· polyethylene bottles. 
3.2.2 Atomic. Absorption Standards 
Banco(Anderson Labs, Ft. Worth, Texas) 1000 ppm 
copper and zinc a tomi.c absorption standards were used in 
this work. Standards of lower concentration were 
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prepared from these standards by dilution wi th____±._h_e_pr_e_\li_o_usl_y-~~­
described water. 
3.2.3 Polyethylene Containers · 
Samples and atomic.absorption standards were stored 
in linear polyethylene containers. The plasma samples were 
stored in conventional polyethylene microcentrifuge tubes. 
3.2.4 Syringes 
All flow injections for atomic absorption were done 
with a 10 ~L Hamilton #701 syringe. 
3.2.5 Atomic Absorption Lamps 
The zinc hollow cathode lamp was from Cathodeon-
Sadtler, 3QNY/Zn, Serial #79273. The copper hollow cathode 
lamp was from Cathodeon-Oriel, #6827-1, Serial #65914. 
CHAPTER FOUR 
4. Results and Discussion 
Procedures for atomic absorption analysis by flow 
----~i-n-;j-ee-t-:i:-on-were-d-evBro-p-e-Q-fu-r-t-h e as sa.y . of . copper and------zinc in 
10 ~1 samples of plasma from age dependent audiogenic 
seizure susceptible mice. The analysia procedure has a 
precision of less than 10 %RSD at a copper or zinc 
concentration or 1.0 ppm. The flow injection apparatus was 
designed with a pulseless liquid flow control system. Flow 
regulation is accomplished by varying the.inert gas pressure 
on the pressurized solvent reservoir. The aspiration 
solvent is 6%(v/v) t-butanol in.water •. After exhaustive 
parameter optimizations,-copper assays were conducted with 
the conventional air-acetylene flame at. 324 •. 754 nm and 
zinc assays were conducted with the unconventional argon-
hydrogen air diffusion flame at 213.856 nm. The aspiration 
solvent was chosen. because it enhanced. the. signal without 
precipitating the plasma. proteins. The argon-hydrogen 
flame system was chosen because it absorbs very little 
ultraviolet light at .the analytical wavelength for zinc 
(213.856 nm). 
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The developed methods for. atomic.absorption by flow 
injection were usBd to. determine the concentration of 
copper and zinc in plasma· samples from six strains(C57BL/6J~ 
LG/J, DBA/2J, SJL/J, BALB/cJ, and LP/J). o£ male and female 
audiogenic seizure ·susceptible mice, aged 18 to 65 days. 
The results ar~e_p_r_e_s_en±_e_d_in.-2k-s-e-ts~o-f,__.da-ta-an-d-g-~a-p-hs-----­
of metal concentrations versus mouse age. 
The data and graphs of plasma copper and zinc 
concentration versus mouse age for the six strains of mice 
are presented in the Appendix. A linear least squares 
reduction of these data is. presented in Table and Figure 
4.1.1 for copper and 4.2.1. for zinc. For ease of viewing, 
twelve o~ these lin~s are presented.on the same graph 
in Figures 4~1.1 and 4.2.1. An averaged linear least 
squares reduction o.f the. reduced data is pres en ted in 
Figure 4.1.2 for copper. and 4.2.2 foD zin~. This line 
represents the average copper or zinc concentration versus 
age for· all strain~ and sexes. 
- -----~--~~ 
1 1 1 
TABLE 4.1.1 
Linear Least Squares Calculated.Copper Concentrations by Age 
Cu, ppm at Age, Days 
# Strain Se.x n Corr. .Slo.pe .0 20 40 60 
-1 c 5~9~B-I:,f~6,;-. -Na-:t-e~-~-4~G---;-l:-·1-37-------:;;-0---;-ou-3-i_i_~-n-r-:-o~o~9~0----:-8 I 
2 C57BL/6J Female 14 0 •. 0994. 0..0033 0.9 1 • 0 1 • 1 1 • 1 
3 LG/J Male 16 0.3278 0 •. 0098 0.8 1 • 0 1. 2 1 • 4 
4 LG/J Female 13 0.2905 0.0075 1 •. 0 1 • 1 1 .3 1.4 
5 DBA/2J Male 15 -0.4332 -0.0109 1 .5 1 • 3 . 1 • 1 0.8 
6 DBA/2J Female 13 .0 •. 1575 0.0037.1.0 1 • 0 1 • 1 1.2 
7 SJL/J Male 19 0.2941 0.0065 1 • 0 1.1 1 .2 1 .3 
8 SJL/J Female 22 0.1659 0 •. 0040 1 • 0 1 • 1 1 .2 1.3 
9 BALB/cJ Male 14 -0 .1692: -0.0082 1 • 6 1. 4 1 • 3 1 • 1 
10 BALB/cJ Female. 16 -0.2020 -0.00-78 1 • 7 1 • 5 1 • 3 1 • 2 
11 LP/J Male 10 -0.2062 -0.0052 1 .3 1.2 1 • 1 1 • 0 
12 LP/J Female 1 1 -0.1543 -0.0036 1 • 3 1 • 2 1 • 1 1 • 0 
FIGURE 4.1.1 
Copper Concentration versus Age for.the Plasma of 
Six Strains of.Male and Female Mice 
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FIGURE 4.1.2 
Average Copper Concentrat~on. versus Age for the Plasma of 
Six Strains of Male and Female Mice 
n = 4 
Correlation = -0.8452 
Slope = -0.0003 
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TABLE 4.2.1 
Linear Least Squarea Calculated Zinc Concentration by Age 
Zn~ ppm at Age, Days 
# Strain Sex n Cor~~ Slope . 0 20 40 60 
1 C57BL/6J Male 14 0.6735 0.0242. 0.5 1 • 0 1 ._4_1_._9 
2 C57BL/6J Female 1.3 0.3982 0.0121. 0.9 1 • 1 1. 4 1 • 6 
3 LG/J Male 16 0 .. 4891 0.0265 0.9 1.4 1 • 9 2.4 
4 LG/J Female 15. 0.5959 0.01.47 1 • 0 1 • 3 1. 6 1 • 9 
5 DBA/2J Male .13 0 •. 4209 .. 0. 0140 0 .• 9 1 .2 1 • 4 1 • 7 
6 DBA/2J Female 13 .. 0 •. 7826 .0 .. 0200 0..6 1 .o 1. 4 1 .8 
7 SJL/J Male 22 0.5170 0.0099 1.2 1.4 1. 6 1 • 8 
8 SJL/J Female 21 0.5557 0.0160 0.9 1.3 1. 6 1 • 9 
9 BALB/cJ Male 12 0 ... ,1444. 0.0060 1 .•.. 1 1.2 1.4 1 • 5 
10 BALB/cJ Female. 13 0.2372 0..,0057 1 .1 1.2 1 .3 1.4 
11 LP/ J Male 12 0.6482 0 •. 0285 0 • .3 0.8 1 • 4 2.0 
12 LP/J Female 11 0.399 3 0.0173.0.9 1 .• 2 1 • 6 1 • 9 
FIGURE 4.2.1 
Zinc Concentration versus Age for the Plasma of 
Six Strains of Male and Female Mice 
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Average Zinc Concentration versus Age for the Plasma of 
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The copper concentration, within the precision of the 
·data, is 1.2 ppni: ±. 0.:2 SD for all sexes, strains, and ages. 
The zinc concentration, within the precision of the data, 
increases· from 1 •. 2 ppni + 0.2 SD at twenty days of age to 
1.8 ppni ±. 0.2 SD at sixty days of age for all sexes and 
strains •. 
There is no correlation between the age dependence of 
the seizure susceptibility of any sex or strain of mice and 
their plasma concentrations or concentration ratios for 
either copper or zinc~ .. If there were a correlation between 
the copper or zinc.plasma. concen~ration and the seizure 
susceptibility we would expect to observe a significant 
copper or z.in.c plasma concentration change that would 
profile the age dependency of the seizure susceptibility. 
Such an age dependent concentration profile was not found. 
The copper and.zinc plasma concentration as a function of 
age does not follow the seizure susceptibility profile as 
a function of age for any.strain or sex of mice studied. 
At any age there is no correlation between the relative 
seizure susceptibility among the strains of mice and their 
concentrations or aoncentration ratios of either copper or 
zinc. If there were a correlation it should follow the 
interstrain seizure susceptibility pattern of LP/J > DBA/2J > 
SJL/J > LG/J > SALB/cJ > C57BL/6J. 
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Such a correla.tion. was. n.ot observed. 
The age dep~ndence of the percentage audiogenic seizure 
susceptibility in these strain.s of mice is very large,. 
ranging ·from zero to. ov.er 97 percent susceptibility. This 
was· shown by the work of. Ham burgh and Vicari ( 33) and later 
by the work of Fuller and Sjursen(34). 
s-ince a correlat-ion between the age dependence of the 
audiogenic seizure susceptibility of the mice and their 
plasma copper or zinc concentration was not found, within 
the precision of the data, we conclude that such correlations 
probably do not exist. This result and the lack of any 
correlation between the relativeinterstrain seizure 
susceptibilities and the copper.or zinc plasma concentrations 
suggests the absence of any correlation between copper or 
zinc plasma concentrations and seizura susceptibility. 
Various authors(J6,37,38) have reported elsvated serum 
copper concentrations of.approximately.1 .. 3 ppm.±. 0.2 SD in 
epileptic humans recei.ving medica.tion. ver·sus concentrations 
of appr6xima·tely 1. 1. ppm + 0 •. 1 .. SD. in human controls. 
Ola tun bosun has· also repo.rted the decrea·se of serum zinc 
concentrations from approximately. 1 .. 0 ppm+ 0.1 SD in human 
controls to approximately 0.8. ppm.±.. 0.1. SD in human 
epileptics receiving medication(J7). 
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It is thus very interesting that we did not find elevated 
copper and reduced zinc plasma concentrations in our series 
of inbred strains of age dependent audiogenic seizure 
susceptible mice. 
These results suggest two interesting experiments. The 
first experiment would be to determine the concentration of 
copper and zinc in the plasma of human epileptics who had 
not been receiving anticonvulsant medication. The second 
experiment would be to determine the age dependence of the 
copper and zinc plasma concentrations for our series of 
audiogenic seizure susceptible mice who had been receiving 
anticonvulsant medication. 
These additional experiments would te.ll whether 
anticonvulsant medication raises the concentration of 
copper and lowers the .concentration of zinc in the plasma 
of human epileptics. If it does not~ the validity of using 
audiogenic seizure susceptible mice as a model for human 
epilepsy is very much in doubt. 
CHAPTER FIVE 
5. Claims to Originality 
1. Sensitivity was enhanced by a factor of 1.7 
(Table 1.3.8~1) for atomic absorption flow injection 
analysis methods by the use ~f a mixed aqueous-organic 
solvent, 6%(v/v) t-butanol in water, instead of water. 
2. Sensitivity was increased by a factor of 1.25 
(Figure 1.3.3.1) for atomic absorption flow injection 
analysis methods by the use of an argon-hydrogen air 
diffusion· flame· instead of an air-ac.etylen.e flame. 
3. A set of procedures was developed to enable an 
analyst to increase the precision.and sensitivity of the 
results· obtained from atomic absorption.flow injection 
analysis assays by systematically optimizing the 
instrumentation parameters~ The application of these 
procedures to the analytical system will result in a set 
of optimal instrumentation parameters •.. 
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4. Atomic absorption. flow: in.j ection: analysis methods 
were· applied to the analysis. of viscous,. salty, aqueous 
and/ or organic, and. very complex fluids such as plasma 
and serum by the use of mixed aqueous-organic solvents to 
keep such fluids in solution in the solvent stream. 
5. Data were obtained. for the concentration of 
copper in the plasma of six strains(C57BL/6J, LG/J, DBA/2J, 
SJL/J, BALB/cJ, LP/J) of audiogenic seizure susceptible 
mice, aged 18 to 65 days. 
6. Data were obtained for the concentration of 
zinc in the plasma of six s.trains (C57BL/6J, LG/J, DBA/2J, 
SJL/J, BALB/cJ, LP/J) of audiogenic seizure susceptible 
mice, a~ed 18 to 65 days. 
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A. Tables and Figures of Plasma Copper and Zinc 
Concentrations by Age 
A.1 .1 
Age~ 
Days 
26 
27 
28 
29 
31 
32 
33 
34 
35 
37 
39 
41 
43 
44 
Tables of Plasma Copper Concentrations by Age 
TABLE A .. 1.1.1.1 
Male C57BL/6J Plasma Copper Concentration~ by Age 
Cu, ppm 
0.9, 0.9 
1.2 
0.6, 0.5, 0.5, 1.0, 1 • 1 , 
1 .1 
1 .1 • 0.7, 0.6, 0.7, 0.6, 
0.9, 0.8, 0.6, 0.7 
0.6,. 0.?, 1.0, 0.7 
0.8, 1.0 
1. 0' 0.8, 0.8, 0.7, 0.7, 
2.0,. 1.1' 1 .6, 1.6, 1 • 0, 
1.2,. 1.3,. 1 ~2 
1.0,. 0.9,. 0.8, 0.9,. 1.2, 
1 •. 5' 0.7 
1.0~ 0.8, 0.7, 1 • 1 , 0.8, 
0 •. 8 
1 • 1 ,. 0.9, 0.9, 1.0 
0.8, 0.9, 1 • 0, 1 • 1 ' 0.7 
0.8, 0.6 
1 .1, 
0.7 
0.9, 
1 .1,. 
1 • 1 ' 
0.8, 
0.9,. 
1 • 1 , 
1.0 
1 • 0, 
0.9, 
n 
X 
SD 
-n X 
2 0.9 
1 1.2 
8 0.9 
6 0.7 
4 0.8 
4 0.8 
2 0.9 
14 1 • 1 
3 1.2 
9 1 .o 
8 0.9 
4 1.0 
5 0.9 
2 0.7 
14 14 
5 0.9 
4 0.2 
SD 
o.o 
o .. o 
0.3 
0.2 
0.1 
0.2 
0.1 
0.4 
0. 1 
0.2 
0.1 
0.1 
0 .. 2 
0.1 
14 
0.2 
0.1 
131 
Age, 
Days 
25 
27 
28 
30 
32 
34 
35 
36 
38 
39 
40 
41 
42 
44 
48 
49 
TABLE A.1.1.1.2 
Male LG/~ Plasma Copper Concentrations by Age 
Cu, ppm 
0.8, 0.7, 0.7, 0.7 
1.3, 1.5 
0.9, 0.9, 0.7, 1 • 1 , 
0.8, 0.7, 0 •. 9, 0.7, 
1 • 4, 1.2 
0.9, 1.0, 0.8 
0.9, 1.2, 1.3, 1 • 2, 
1.5, 1.0 
1.0, 1 .1 , 1 .. 0, 1 .J, 
1.6, ·t.3 
0.8, 1.0 
1.0, 1 .. 1 
1. 4,. 1 .6, 0.9 
1.3 
1.3, 1.2, 1 • 0, 1.2 
0.7, 0.8, 1.0,, 1.0,. 
1.4,·1.6 
1 • 1 ' 1 .1 
1 .4, 0.9, 
1.3, 1 .. 0, 
1 .1 ,. 1.3, 
1.2, 1 .8, 
0.8 
1 • 1 
1.5, 
1 • 1 
1 • 6, 
n 
X 
SD 
-n X 
4 0.7 
2 1.4 
7 1 • 0 
9 1 • 1 
3 0.9 
7 1.2 
2 1 .3 
9 1 .3 
2 0 .. 9 
2 1 .1 
3 1.3 
1 1. 3 
4 1.2 
5 0.9 
2 1.5 
2 1 • 1 
16 16 
4 1 • 1 
3 0.2 
SD 
0.1 
0.1 
0.2 
0.3 
0.1 
0.1 
0.4 
0.3 
0.1 
0.1 
0.4 
o.o 
0. 1 
0.1 
0.1 
o.o 
16 
0.2 
0.1 
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Age, 
Days 
26 
27 
32 
33 
34 
35 
36 
38 
40 
41 
44 
45 
47 
49 
52 
TABLE A.1.1.1.3 
Male DBA/2J Plasma Copper Concentrations by Age 
Cu, ppm 
1.4 
1 .2, 1 • 1 
0.9, 1 • 0, 1.0 
1 • 5, 1.2 
0.7 
1 • 2' 1.2 
1.2, 1 .. 1 , 1 • 0 ,. 1 • 1 ,. 1 • 0 
1. 0' 1 .. 1 , 1.3 
0.9, 1.2, 0. 9 ,. 1 •. 2, 1.4 
0.9 
0.9, 1 • 0, 1.1 
0.9 
0.8, 0.9, 1 • 1 
0.9 
1.2 
n 
1 
2 
3 
2 
1 
2 
5 
3 
5 
1 
3 
1 
3 
1 
1 
n 15 
X 2 
SD 1 
-X SD 
1. 4 o.o 
1. 2 0.1 
1 • 0 0. 1 
1 • 4 0.2 
0.7 o.o 
1 • 2 o.o 
1 .1 0. 1 
1 • 1 0.2 
1 .1 0.2 
0.9 o.o 
1 • 0 0.1 
0.9 o.o 
0.9 0.2 
0.9 0.0 
1 .2 o.o 
1 5 15 
1.1 0.1 
0.2 0.1 
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TABLE A.1.1.1.4 
Male SJL/J Plasma Copper Concentrations by Age 
Age, Cu, ppm 
Days 
18 1.1 
19 1 • 2, 1 .3, 1.3 
25 1 • 1 , 1. 2, 1 .J, 1.5, 
26 1 • 1 , 1 • 1 , 1.2 
29 1.3, 1 • 0, 1.3 
30 1.2, 1 • 1 
32 1.2, 1.2, 0..-9 , .. 1. 2, 
35 0.9, 0.8, 0. 9 ,. 0 .• 9, 
36 1.3, 1 .o 
37 1 • 1 , 1 • 1 , 1 • 0,. 1. 0 ,. 
38 . 1. 4, 1. 0, 1.2, 1.2, 
40 1.0, 1.0 
41 1.0, 0. 7, 0.9, 1 • 0, 
42 0.9, 1 • 1 , 1 • 0, 1 • 1 , 
1.6~ 1. 0 
44 0.9, 0.6, 0.9, 1.0 
49 1. 5, 1.8 
50 1. 2, 2.0 
52 1. 5, 1 • 1 , 1. 8, 1.0 
53 1.3 
1 • 4 
1 .1 
0 .• 8, 0.6 
1.0 
0..7, 0.6, 
0.9 
1 • 6, 1 • 4, 
0.8 
1.5, 
n 
X 
SD 
-n X SD 
1 1 • 1 o.o 
3 1.3 0 .. 1 
5 1 • 3 0.2 
3 1 • 1 0.1 
3 1.2 0.2 
2 1 • 2 0.1 
5· 1 • 1 0.1 
6 0.8 0.1 
2 1. 2 0.2 
5 1 • 0 0. 1 
7 1.0 0.3 
2 1. 0 0.0 
5 0.9 0.1 
9 1.2 0.3 
4 0.9 0.2 
2 1.7 0.2 
2 1.6 0.6 
4 1.4 0.4 
1 1.3 o.o 
19 19 19 
4 1.2 0.2 
2 0.2 0.1 
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TABLE A.1.1.1 .. 5 
Male BALB/cJ Plasma Copper Concentrations by Age 
Age, Cu, ppm n -X SD 
Days 
21 1 .3' 1.8, 1 • 0, 1 .3 4 1. 4 0.3 24 1.5, 0.8~ 0.8, 0.8 4 1 .o 0.4 25 1.3, 2.1, 1 • 6, .1.3 4 1 • 6 0.4 28 1. 7, 2.4 2 2.1 0.5 29 1. 4, 1.5 2 1 • 5 0.1 
31 1 •. 1 , 0.8 2 1 • 0 0.2 
32 1 .. 1 1 1 • 1 o.o 
35 1 .6, 1. 4,. 1 .o' 1.2, 1 • 0, 0.8, 0.7 7 1 .1 0.3 
37 1.3 1 1.3 o.o 
39 0.7, 0.7 2 0.7 o.o 
40 1. 4 1 1.4 o.o 41 1. 4 1 1.4 o.o 
43 1.8 1 1 • 8 o.o 
45 1 • 0 1 1 • 0 0.0 
n 14 14 14 
X 2 1.3 0.2 
SD 2 0.4 0.2 
Age,. 
Days 
22 
27 
28 
34 
37 
41 
45 
49 
50 
54 
TABLE A.1.1.1.6 
Male LP/J Plasma Copper Concentrat~ons by Age 
1. 4 
0 .. 9, 
1 .. 2, 
1 • 1 , 
1.1 , 
1.7, 
0.6 
1.0 
1.0, 
1.3, 
0.8 
1 .. 2 
1'.3 
0.8 
1. 5 ,. 
1.2 
1 .1 
Cu, ppm 
1.5 
n 
X 
SD 
n 
1 
2 
2 
2 
2 
3 
1 
1 
2 
2 
10 
2 
1 
-X 
1.4 
0.9 
1.2 
1. 2 
1.0 
1.6 
0 •. 6 
1.0 
1.1 
1.2 
10 
1 • 1 
0.3 
SD 
o.o 
0.1 
o.o 
0.1 
0.2 
0.1 
o.o 
o.o 
0.1 
0.1 
10 
0.1 
0.1 
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Age, 
Days 
27 
28 
29 
31 
32 
33 
34 
35 
37 
39 
41 
43 
44 
48 
TABLE A .. 1.1.2.1 
Female C57BL/6J Plasma Copper Concentrations by Age 
Cu, ppm 
0.8, 0.5, 2.7, 1 • 5 
0.6, 0.7, 0.5, 0.6, 0.5, 0.9, 
1 • 0,. 1.0, 1.2 
0.7, 1.0 
0.8 
0.8, 0 ... 7, 0.5 
0 .. 8, 0.7, 0.8, 0.8, 1. 4, 1. 4, 
' 1 •. 3, 1.2 
1.1 
1 .1 ,. 1 .. 3, 1 .3, 1 .1 , 1 .3, 1 .1 , 
1 .. 5' 0.6,. 1.0, 1.1 
1 • 5, 0.8,. 1.0 
1. 5, 0.9, 0~9 
1 • 0, 1.6 
0.8, 0.8 
1 • 0, 0.9 
1 • 1 ,. 
1.3 
1.3, 
n 
X 
SD 
-n X SD 
4 1 • 4 1 • 0 
10 0.8 0.3 
2 0.9 0.2 
1 0.8 o.o 
3 0 .. 7. 0.2 
7 1 • 0 0.3 
2 1. 3 0. 1 
1 1 • 1 o.o 
1 1 1 • 2 0.2 
3 1 • 1 0.4 
3 1 • 1 0.3 
2 1 • 3 0.4 
2 0.8 o.o 
2 1 • 0 0.1 
14 14 14 
4 1.0 0.3 
3 0.2 0.3 
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Age, 
Days 
27 
28 
32 
34 
36 
38 
40 
41 
42 
44 
48 
61 
64 
TABLE A.1.1.2.2 
Female LG/J Plasma Copper Concentrations by Age 
1.5 
0.9, 1 • 3, 
1 .. 2, 1 .. 4 
0.7, 0 .. 8 
1. 5, 1.5, 
1 • 1 , 1. 4, 
0.9, 0.9 
1 .. 0, 0.6, 
1.6 
1. 7, 1.0 
0.8, 1.0, 
1.6 
1.7 
1.2 
Cu, ppm 
1.2, 1.5, 
1 • 1 , 1. 4 
1.2, 1.2, 
1.3 
1.3, 0.8 
1.2, 1 • 1 ,. 
1 .1, 1.2 
1.0,. 
n 
X 
SD 
n 
1 
9 
2 
4 
6 
2 
3 
1 
2 
4 
1 
1 
1 
13 
3 
2 
-X 
1 • 5 
1. 2 
0.8 
1.4 
1. 2 
0.9 
1 • 0 
1. 6 
1.4 
1 • 0 
1 • 6 
1. 7 
1 • 2 
13 
1 • 3 
0.3 
SD 
o.o 
0.2 
0.1 
0.2 
0.1 
o.o 
0.4 
o.o 
0.5 
0.2 
o.o 
o.o 
o.o 
13 
0.1 
0.2 
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Age, 
Days 
27 
32 
34 
35 
36 
38 
40 
41 
45 
49 
50 
52 
54 
TABLE. A •. 1.1.2. 3 
Female DBA/2J Plasma Copper Concentrations by Age 
Cu, ppm. 
1 • 1 , 1.2,. 1 .. 2 
1 • 2, 0.9, 1 • 1 
0 ... 8, 0.8 
1.2, 1.1 " 1 • 0, 1.5 
1 • 0, 1 ... 2 
1 .. 1, 1 .4, 1 .. 2 
1.3, 1.3, 0.9, 0 ... 9, 1 •. 3, 1.0 
1 .. 2, 1 •. 1 
0.8, 0.7, 0 .. 6. 
1 .. o" 1 .1 
1 .. 1 ; 1 •. 6, 1 .. 7 
1 • 1 , 1.2,. 1.0 
1 •. 2 
n 
3 
3 
2 
4 
2 
3 
6 
2 
3 
2 
3 
3 
1 
n 13 
X 3 
SD 1 
-X SD 
1. 2 0. 1 
1 • 1 0.2 
0.8 o.o 
1. 2 0.2 
1 • 1 0.1 
1 • 2 0.2 
1 • 1 0.2 
1. 2 0. 1 
0.7 0.1 
1 • 1 0. 1 
1 •. 5 0.3 
1 • 1 0.1 
1.2 o.o 
13 13 
1.1 0.1 
0.2 0.1 
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Age,. 
Days 
18 
19 
23 
25 
26 
29 
30 
32 
35 
36 
37 
38 
39 
40 
41 
42 
44 
45 
49 
50 
52 
53 
TABLE A.1.1.2.4 
Female SJL/J Plasma Copper Concentrations by Age 
Cu, ppm 
1.1,. 0.8, o.. 8 ,, 1 • 1, 0.9 
1.2 
1.1,. 1 •. 0 ,. Q a8 J• 1 .o 
1.2 
1.7 
1 .. 0,. 1 .. 4,. 1.2 
1.2, 1 .. 3 
1 •. 3 ,. 1.2, 1.3, 1.2 
1 .. 0,. 1 .. o, 1 .. 0, 1.2, 1.2, 
0.8,. 0 ... 8,. 0 .. 8 
1.2, 1 .0 
1 • 1 ' 1 .o' 1 • 1 , 0.-9 ,. 1 • 1 , 
1.3,. 1.3, 0.7, 0.6, 0 •. 6, 
0.6 
1.7, 1.3 
0.9, 0.9, 0.9, 1.1 ,. 1.6 
0.9, 0.8, 1 .o, 0.8, 0.9 
1 • 1 ,. 1.2, 1.2,. 1 • 5,. 2.0, 
0.7, 0.7, 0.8, 0.9, 0.9, 
1 • 6, 1.6 
1.2 
1 • 1 , 1 • 1 , 1 • 3, 0.9, 1 • 0 
1 • 1 , 1.9 
1.0 
0.9, 2.4, 2.2, 1.3 
0.7, 
0.9 
0.8, 
1 • 3 
0.8, 
0.7, 
0.7, 
1 • 9, 
n 
X 
SD 
n 
5 
1 
4 
1 
1 
3 
2 
4 
10 
2 
6 
8 
2 
5 
5 
6 
9 
1 
5 
2 
1 
4 
22 
4 
3 
-X 
0.9 
1.2 
1.0 
1.2 
1 •. 7 
1 .. 2 
1 .3 
1 .. 3 
0.9 
1 • 1 
1 • 0 
0.8 
1 • 5 
1 • 1 
0.9 
1. 4 
1 • 1 
1.2 
1 .. 1 
1 • 5 
1.0 
1 • 7 
22 
1.2 
0.3 
SD 
0.2 
o.o 
0.1 
o.o 
o.o 
0.2 
0.1 
0. 1 
0.2 
0.1 
0.1 
0.3 
0.3 
0.3 
0.1 
0 .. 3 
0.5 
o.o 
0.1 
0.6 
o.o 
0.7 
22 
0.2 
0.2 
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Age, 
Days 
21 
25 
28 
29 
30 
31 
32 
35 
37 
40 
41 
42 
43 
45 
51 
54 
TABLE A.1.1.2.5 
Female BALB/cJ Plasma Copper Concentrations by Age 
1 • 5 t 1 .. 3 
1 .. 5, 1. 5, 
1. 9, 1.7, 
1 .. 6 ,. 2., 1 t 
1.0, 1 .. 2 
1.0, 1.0 
1. 7, 1 .. 8, 
1 .. o, 1 .3, 
1 .. 6 
1 .o, 2 .. 0, 
1.8 
1. 0, 0.9, 
2 •. 1 
1 .o, 1.0, 
0 .. 9' 0 .. 8, 
1.0 
Cu, ppm 
1.4,. 1 .3 
t .J ,. 1.6, 1 •. 5 
1 .3 
1 •. 4,. 1 • 0, 1.0 
1 .. 0 ,. 0.8, 0.8 
2.1 
1 •. o., 1.0, 0.9 
1.1 
1 •. 4 
n 
X 
SD 
-n X SD 
2 1.4 0.1 
4 1.4 0. 1 
5 1. 6 0.2 
3 1.7 0.4 
2 1 .1 0. 1 
2 1 .a o.o 
5 1. 4 0.4 
5 1 • 0 0.2 
1 1.6 o.o 
3 1.7 0.6 
1 1 • 8 o.o 
5 1 .o 0. 1 
1 2.1 o.o 
3 1.0 0. 1 
3 1.0 0.3 
1 1.0 0.0 
16 16 16 
3 1.4 0.2 
2 0 .. 4 0.2 
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Age~ 
Days 
22 
26 
32 
34 
36 
37 
41 
43 
44 
50 
54 
TABLE A.1.1.2.6 
Female LP/J Plasma Copper Concentrations by Age 
1.0 
1 .. 4 
0.8 
1 .. 2, 1 .1 
1 .. 2 
1.8, 1.2, 
1 .. 6 
1 .0, 1.3 
1 .. 1 , 1 .1 
1.0 
0.9 
Cu, ppm 
0.8, 0.8 
n 
X 
SD 
n 
1 
1 
1 
2 
1 
4 
1 
2 
2 
1 
1 
1 1 
2 
1 
-X SD 
1 • 0 o.o 
1.4 o.o 
0.8 o.o 
1.2 0.1 
1.2 o.o 
1.2 0.5 
1.6 o.o 
1.2 0.2 
1 • 1 o.o 
1 .o o.o 
0:9 o.o 
11 11 
1.1 0.1 
0.2 0.2 
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A.1.2 Tables of Plasma. Zinc Concentrations by Age 
TABLE A.1.2.1.1 
Male C57BL/6J Plasma Zinc Concentrations by Age 
----A-f.fe-y------,Zn--,------J:3pm---------n--i--s-JJ-------
Days 
23 0 .. 7~ 1. 0 
26 1.0, 1 • 0, 1.2 
27 1. 4 
28 1. 4, 1 • 1 , 0.9 ,. 0.8, 
29 1 .4, 1 • 0 
31 1.0, 1.1 ,. 1.0,. 1.6, 
32 0 .• 8, 1.3, 1 .3 ,. 1.0 
34 1.2,. 1 .1 , 1 • 0, 1 .o, 
1.2, 1 .3 
35 2.0, 1 • 1 , 2.0 
37 1.3, 1 .3, 1 •. 1 , 1 • 2, 
1 • 7, 1 • 8, 1 • 0, 1.7, 
39 0.9, 1.0, 1.2, 1 • 1 ' 
1.5, 0.8, 1.0 
41 1.8,. 1.4, 1.4, 1.6, 
1.3, 1.5 
43 1.6, 1. 4, 1 • 5, 2.0, 
44 2.0, 1. 6' 1. 6, 1.3, 
1 • 1 , 1 •. 4 
1.3 
1 .1 , 1. 4, 
1. 5, 1 • 1 , 
0.7, 0.9, 
1 • 3, 1 • 2' 
1 • 4, 1 • 8, 
1.6 
1.2 
2 
3 
1 
6 
2 
5 
4 
1.3, 
9 
3 
1 • 5, 
1. 4 14 
1.3, 
1 • 8, 
n 
X 
SD 
10 
9 
5 
5 
14 
6 
4 
0.9 
1 • 1 
1.4 
1 • 1 
1 .2 
1.2 
1.1 
1.2 
1 • 7 
1 • 3 
1 .1 
1 .6 
1.6 
1.5 
14 
1.3 
0.2 
0.2 
0.1 
o.o 
0.2 
0.3 
0.3 
0.2 
0.1 
0.5 
0.3 
0.2 
0.2 
0.2 
0.3 
14 
0.2 
0.1 
Age, 
Days 
23 
25 
27 
28 
30 
32 
34 
35 
36 
38 
39 
40 
42 
44 
48 
49 
TABLE A.1.2.1.2 
Male LG/ .T Plasma Zinc Con.centra tions by Age 
Zn, ppm 
1. 6,. 1.2, 0.9 
2.2, 2. 0 ,. 1.9,. 2.3 
1. 4, 1.6 
1 • 5, 1.3, 1. 9,. 1 • 1 
1. 8, 1.8, 2.0, 1 • 6, 1 • 3 ,. 1.2, 
2.1, 1 .. 2, 1.6 
2.0, 2.7, 
1.6 
2 ... 4,- 2 •. 4., 1 • 9, 1. 5, 
2.4~ 2 .. 0,. 1.5 
1 • 9, 2.3, 2.4, 
1.4 
1.5, 1 • 6, 1 • 6' 
2.0,. 1. 7 
2 .. 5, 2.2 
0.7, 1. 4, 0.8 
2.4,. 1 • 8' 1 • 5,. 1 • 1 
2.2, 2.2, 1. 6, 2. 0 ,. 2.0, 1.5 
2.0 
1. 8, 3.6 
0.6 
1 • 4, 
1 • 2, 
n 
X 
SD 
-n X SD 
3 1.2 0.4 
4 2.1 0.2 
2 1 • 5 0.1 
4 1 • 5 0.3 
7 1 • 5 0.5 
3 1 • 6 0.5 
8 2.0 0.5 
3 2.0 0.5 
8 1. 7 0.4 
2 1.9 0.2 
2 2.4 0.2 
3 1 • 0 0.4 
4 1. 7 0.5 
6 1 • 9 0.3 
1 2.0 o.o 
2 2.7 1 •. 3 
16 16 16 
4 1.8 0.4 
2 0.4 0.3 
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Age, 
Days 
24 
26 
27 
32 
35 
36 
38 
40 
41 
44 
47 
49 
52 
TABLE A.1.2.1.3 
MalE DBA/2J Plasma Zinc. Concentrations by Age 
Zn, ppm 
1.3, 1.6 
1. 4 
1.1 ' 1 .4, 1. 0. 
1.0 
0 .. 9, 1.3, 1.3 
1 • 9, 2.0, 1. 4, 1 •. 4,.. 1 • 7 
0.5, 1 • 0, 1 .2. 
1.3, 1 • 3, 1 • 6' -1 .J ,. 1 • 6, 1 • 3, 
2.3, 2.0, 1.8 
1 ., l" 
1 .. 6,. 1.3 
1.7, 1 • 9,. 1 .. 4, 1.4 
1 .. 9 
1.6 
1.9, 
n 
-X 
SD 
-n X SD 
2 1 • 5 0.2 
1 1.4 o.o 
3 1 • 2 0.2 
1 1 • 0 o.o 
3 1. 2 0.2 
5 1. 7 0.3 
3 0.9 0.4 
10 1. 6 0.4 
1 1 • 1 o.o 
2 1.5 0.2 
4 1. 6 0.2 
1 1.9 o.o 
1 1 .. 6 o.o 
13 13 13 
3 1.4 0.2 
3 0.3 0.2 
145 
146 
TABLE A.1.2.1.4 
Male SJL/J Plasma Zinc Concentrations by Age 
Age, -X SD Zn, ppm n 
Days 
18 1.7 1 1.7 o.o 
19 1.4, 1 •. 1 2 1.3 0.2 
23 1.4 1 1.4 o.o 
25 1.4,. 1.3 2 1.4 0.1 
26 1.2, 2.2 2 1.7 0.7 
29 1.6, 1 • 1 2 1.4 0.4 
30 1.9,.· 1.J,.· 1.,5 ,. 1 ... 1 ' 0.9 5 1.3 0.4 
31 1 .3, 1 •. 3, 1 .6,. 1 .6 . 4 1.5 0.2 
32 1.6,. 1.8 2 1.7 0.1 
35 1. 4. 1.3,. 1.4 3 1.4 0.1 
36 1.1', 1.4 2 1.3 0.2 
37 1.6, 1 .. 5, 1 •. 4 3 1 .5 0.1 
38 1.8, 1. 9' 1.6,. 1 .-5 4 1.7 0.2 
40 1.8, 1.2 2 1 • 5 0.4 
41 2.0, 1.8,. 1.6, 1.5,. 1.6, 1.4 6 1.7 0.2 
42 0.9, 1.7, 1 •. 4,. 2 .. 0, 1.2 5 1.4 0.4 
44 1.7, 2.1, 1.6 3 1.8 0.3 
45 1.9 1 1.9 o.o 
49 1.2,. 2.1, 1.5,. 1.6 4 1.6 0.4 
50 1.5, 1.7 2 1.,6 0.1 
52 1. 8,.. 1.1 , 1.9, 2.1,. 1 • 9, 1.6 6 1.7 0.4 
53 1.7, 2.3 2 2.0 0.4 
n 22 22 22 
x 3 1.6 0.2 
SD 2 0.2 0.2 
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TABLE A.1.2.1.5 
Male BALB/cJ Plasma Zinc Concentrations by Age 
Age, Zn, ppm n -X SD 
Days 
21 0.6, 0.9 2 0.8 0.2 
24 2.0, 1.4 2 1.7 0.4 
25 1.2, 1 • 1 ' 1.1 3 1 • 1 0. 1 
28 1.0, 1.3 2 1.2 0.2 
29 1 .o' 1.4 2 1 •. 2 0.2 
30 1.6 1 1.6 o.o 
32 1.5 1 1 • 5 o.o 
33 1.8, 1 •. 6. 2 1 • 7' 0.1 
35 1.2, 1 • 1'' 0 •. 9, 1.2 4 1 •. 1 0. 1 
37 1 .3', 1.7 2 1.5 0.3 
41 0.7, 1.2 2 1 .o 0.4 
45 1.5, 1.2 2 1.4 0.2 
n 12 12 12 
X 2 1.3 0.2 
SD 1 0. 3 0.1 
--------------------
TABLE A.1.2.1.6 
Male LP/J Plasma Zinc Concentrations by Age 
Age, 
Days 
22 0.4 
27 1 .2,.. 
28 1 .. 5 
32 1.2 
34 1 .1 
37 1 •. 2, 
39 1 .. 7 
41 1.4,. 
42 1.2 
43 1 .. 9, 
49 1 .. 3 .. 
50 2.0 
1 .. 3 
1.4,. 
1.3 
1 .4,. 
Zn, ppm· 
1 •. 1 
1.3 
n 
X 
SD 
n 
1 
2 
1 
1 
1 
3 
1 
2 
1 
3 
1 
1 
12 
2 
1 
-X SD 
0.4 o.o 
1.3 0.1 
1 • 5 0.0 
1.2 o.o 
1.1 o.o 
1.2 0.2 
1 •. 7 0.0 
1.4 0.1 
1.:? o.o 
1.5 0.3 
1.3 o.o 
2.0 o.o 
12 12 
1.3 0.1 
0.4 0.1 
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Age, 
Days 
23 
28 
29 
31 
32 
33 
34 
35 
37 
39 
41 
43 
44 
~-~ ~------
TABLE A.1.2.2.1 
Female C57BL/6J Plasma Zinc Concentrations by Age 
Zn, ppm 
0.9, 1 .. o, 1.4 
1.3, 1 .2 , .. 1 •. 4,. 1 •. 3, 1 .3' 
1.3 
1 ~-4 
1 .. 4, 1.5,. 1 • 1 
1 • o·, 1.2, 1 .• 2 
1 .4-, 1.7,. 0.9 
1 • .3, 1. 5· 
1.2,. 1.6 
1 •. 4, 1. 5' 1. 8 ,. 1. 7, 1.6, 
1. 4, 1.5, 1 .3, 1 •. 2,. 1.3, 
1 • .5' 0 •. 9 
1 • 2, 1 • 1 , 1.3 
1. 4, 1. 4, o. 9· 
1.3, 1 .1 
2 •. 0' 1. 7, 1.6 
1 • 6' 
1.8, 
1 • 9, 
1 •. 3 ,. 
1.4, 
1.7, 
n 
X 
SD 
-n X 
3 1 • 1 
8 1 .3 
1 1.4 
3 1. 3 
3 1 • 1 
3 1 • 3 
2 1.4 
2 1.4 
16 1.5 
3 1.2 
3 1.2 
2 1.2 
3 1.8 
13 13 
4 1.3 
4 0.2 
SD 
0.3 
0. 1 
o.o 
0.2 
0.1 
0.4 
0.1 
0.3 
0.3 
0.1 
0 .. 3 
0.1 
0.2 
13 
0.2 
0.1 
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TABLE A. 1 • 2 •. 2. 2 
Female LG/J Plasma Zinc Concentrations by Age 
Age, Zn, ppm n -X SD 
Days 
23 1.6, 1.5 2 1.6 0.1 
27 1. 4 1 1. 4 o.o 
28 1.2,. 1 .5, 1 •. 4, 1.3 4 1. 4 0 •. 1 
30 1.2. 1 1.2 o.o 
32 1. 4, 1'.5, 1 .. 2 3 1.4 0.2 
34 0.9, 0.8, 1. 8 3 1.2 0.6 
36 1. 4, 1 .o, 1 .2,.. 1 .. 2, 1.5 5 1.3 0.2 
38 1. 8 , .. 1 .. 8 2 1.8 o.o 
39 2.0· 1 2.0 o.o 
40 1 •. 7, 1.7, 1.9 3 1.8 0.1 
42 2. 0 ,. 1 .4, 1 .. 1 3 1 .. 5 0.5 
44 1.8, '1.8,. 1.9,. 1.3 4 1.7 0.3 
49 1.4 1 1.4 o.o 
60 1 .. 9 1 1.9 o.o 
61 2.1, 1.8, 2.2 3 2.0 0.2 
n 15 15 15 
X 3 1.6 0.2 
SD 1 0~3 0.2 
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TABLE A.1.2.2.3 
Female DBA/2J Plasma Zinc Concentrations by Age 
Age, Zn, ppm -X SD n 
Days 
24 1.3, 1.3 2 1.3 o.o 27 1.0, 1 .1, 1 ... 1. 3 1 .1 0.1 32 1 .. 4 1 1.4 o.o 
35 1. 0 ,. 1.2·, 1 •. o 3 1 • 1 0.1 36 1. T, 1.2 2 1.5 0.4 38 1.3 1 1 .3 o.o 40 1.0, 1 .. 2, 1 .,4,. 1 .. 1.,. 1.3, 1..6, 1 •. 6 7' 1 .3 0.2 41 1 • 1 ,. 1 •. 1', 1.5 3 1.2 0.2 
. 48 1.9·, 1.5 2 1.7 0.3 
49 1 .3 ,· 1 .;5,. 1.7 3 1 .. 5 0.2 50 1 .. 6 1 1.6 o.o 52 1 .7, 1.6,. 1 .8. 3 1.7 0.1 54 1 .. 5' 2.2 2 1. 9 0.5 
n 13 13 13 
X 3 1.4 0.2 
SD 2 0.2 0.2 
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TABLE A.1.2.2.4 
Fema·le SJL/ J Plasma. Zinc Concentrations by Age 
Age~ Zn,. ppm n -X SD 
Days 
18 1.3,. 1 .3,.. 1..2.,. t. 4, 1.4 5 1.3 0.1 
23 1.1 ' 1 .. 1 , 1."'0,. 1. 4. 4 1. 2 0.2 
25 1.9 1 1 • 9 o.o 
26 1.3 1 1. 3 o.o 
29 1.0, 1 .. 4 2 1. 2 0.3 
.30 1.5, 2.2, 1. 0.,. 1.0,. 1 • 1 5 1. 4 0.5 
.31 1.2, 1. 5 ,. 1. •.. 6., 1 .. 4, .. 1 .4, 1. 4 6 1. 4 0.1 
.35 2.0,. 1.4, 1. 4, 1.7, 1 •. 8, .1 .. 6.,. 2.2 7 1.7 0 • .3 c 
-36 1 • 0,. 1'.4 2 1 .2 0.3 ~ 
.37 1.8, 1.2, t .. J, 1.2 4 1 .. 4 0.3 i E 38 1.5, 1.6, 1 .J, 1. •. 1., 1.2, 1 •. 1 6 1 • .3 .0.2 E 
39 1.9, 1'.9, 1. 7,. 1 .-4 4 1.7 0.2 i 
40 1. 7', 2.o·, 1~6, 1.8 4 1 .8 0.2 
41 1.6,. 1.2,. 1.7, 1.9, 1. 6 . 5 1.6 0 • .3 
42 1 • 6, 1.0, 1.2,. 1.7, 0.4 5 1. 2 0.5 
44 1.6,. 2.0, 1.5, 1. 7, 1 • 9, 0.8, 2.0 7 1.6 0.4 
45 1. 5, 1 • 9, 2.0, 2.1 4 1. 9 0 • .3 
49 1.7, 1.7, 1.5, 1.7, 1.8 5 1 .. 7 0.1 
50 1.8,. 1.7 2 1 • 8 0.1 
52 2.2 1 2.2 o .. o = ~ 
53 1.9, 1.3, 1.5, 1.6 4 1 • 6 0 • .3 
I 
21 21 21 -n _ .. 
-
X 4 1.5 0.2 = 
SD 2 0.3 0.1 
-
~ 
i 
.. 
~ 
.,. 
-
-
-
-
Age, 
Days 
21 
25 
28 
29 
30 
32 
35 
41 
42 
43 
. 45 
51 
54 
TABLE A .. 1.2.2.5 
Female BALB/c~ Plasma Zinc Concentrations by Age 
Zn, ppm 
1.2,. 0.9 
0 .. 8 ,. 1 .. 4,. 1 .. 1 
1 • .5, 1.4,. 1.8 ,. 1. .. 9 
1 .. 1 , 1.6 
0. 9',. 0.7 
1 .. 3,. 1 .4,. 1 .2,.. 1 .3 
2 .. 1, 0.7, 1 •. 0., .1 .4,. 1.7. 
0.6, 1 .1 
1 .3,. 1 .. J, 1.4,. 1 .4, 1 .4, .1 •. 4 . 
1 .. 1 ,. 1.2 
1 .1,. ·1~4,. 1.2,. 1.3 
1 • .5', 1 .. 3,.·1.6,. 1.8, 1.4 
1 •. 4,. l. 6',. ' 1 • .5, 1.2 
n 
X 
SD 
-n X SD 
2 1.1 0.2 
3. 1.1 0.3 
4 1.7 0.2 
2 1.4 0.4 
2 0.8 0.1 
4 1.3 0.1 
5 1 .. 4 0.6 
2 0.9 0.4 
6 1 •. 4 0.1 
2 1.2 0 •. 1 
4 1.3 . 0 •. 1 
5 1.5 0.2 
4 1.4 0.2 
13 13 13 
4 1.3 0.2 
1 0.2 0.2 
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Age,. 
Days 
22 
26 
32 
34 
37 
39 
41 
42 
. 43 
50 
54 
TABLE A.1.2.2.6 
Female LP/.J Plas.ma .Zinc. Concentrations by Age 
1.0 
1.5 
1.8 
1.7 
1.0, 
1. 5' 
1. 7' 
, 2.3 
1.0, 
1.5 
2.0 
Zn, ppm 
1 .. 0,..0.7, 1 .2 
l.l·,, 1 • 0, 1 .4 . 
n 
X 
SD 
-n X SD 
1 1 • 0 o.o 
1 1.5 o.o 
1 1.8 o.o 
1 1.7 o.o 
4 1.0 0.2 
1 1.5 o.o 
1 1.7 o.o 
1 2.3 o.o 
4 1 .1 0.2 
1 1.5 o.o 
1 2.0 0 •. 0 
11 11 11 
2 1.6 o.o 
1 0.4 0.1 
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Figures of Plasma Copper Concentrations versus Age 
FIGURE A.1.3 .. 1.1 
Hale Pla.sma Co.ppe.r Concentrations 
versus Age for.C57BL/6J Mice 
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FIGURE A.1 •. 3.1.2 
Male Plasma Copper Concentrations 
versus Age for LG/J Mice 
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FIGURE A.1.3.1.3 
Male Plasma Copper Concentrations 
versus Age for DBA/2J Mice 
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FIGURE A.1 •. 3.1.4 
Male Plasma Copper Concentrations 
versus Age for SJL/J Mice 
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FIGURE A.1.3.1.5 
Male Plasma Copper Concentrations 
versus Age for BALB/cJ Mice 
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FIGURE A.1.3.1.6 
Male Plasma Copper Concentrations 
versus Age for LP/J Mice 
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FIGURE A.1.3.2~1 
Female Plasma Copper Concentrations 
versus Age for G57BL/6J Mice 
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FIGURE A.1.3.2.2 
Female Plasma Copper Concentrations 
versus Age for LG/J Mice 
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FIGURE A.1.3.2.3 
Female Plasma Copper Concentrations 
versus Age for DBA/2J Mice 
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FIGURE A.1.3.2.4 
Female Plasma Copper Concentrations 
versus Age for SJL/J Mice 
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FIGURE A.1.3.2.5 
Female Plasma CoppBr Concentrations 
versus Age for BALB/cJ Mice 
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FIGURE A.1.3.2.6 
Female Plasma Copper Concentrations 
versus Age for LP/J Mice 
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Figures of Plasma Zinc Concentrations versus Age 
FIGURE A.1.4.1.1 
Male Plasma Zinc Concentrations 
versus Age for C57BL/6J Mice 
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Male Plasma Zinc Concentrations 
versus Age for LG/J Mice 
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FIGURE A.1.4.1.3 
Male Plasma Zinc Concentrations 
versua Age for DBA/2J Mice 
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FIGURE A.1.4.1.4 
Male Plasma Zinc Concentrations 
versus Age for SJL/J Mice 
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FIGURE A.1.4.1.5 
Male Plasma Zinc Concentrations 
versus Age for BALB/cJ Mice 
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FIGURE A.1.4.1.6 
Male Plasma Zinc Concentrations 
versus Age for LP/J Mice 
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FIGURE A.1.4.2.1 
Female Plasma Zinc Concentrations 
versus Age for C57BL/6J Mice 
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FIGURE A.1.4.2.2 
Female Plasma Zinc Concentrations 
versus. Age for LG/J Hice 
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FIGURE A.1.4.2.3 
Female Plasma Zinc Concentrations 
versus Age for DBA/2J Mice 
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FIGURE A.1.4.2.4 
Female Plasma Zinc Concentrations 
versus Age for SJL/J Mice 
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FIGURE A.1.4.2.5 
Female Plasma Zinc Concentrations 
versus Age fo~ BALB/cJ Mice 
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FIGURE A.1.4.2.6 
Female Plasma Zinc Concentrations 
versus Age for LP/J Mice 
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